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Abstract 
Infectious bronchitis is a highly contagious respiratory disease that results in 
reduced egg production and can be fatal in young birds. It has recently been 
identified as the most economically detrimental disease to the poultry industry. It is 
caused by the gammacoronavirus infectious bronchitis virus (IBV), which is endemic 
in most countries worldwide. All viruses modulate cellular processes to establish 
themselves within the cell. The cellular PI3K/AKT signalling pathway is often 
modified by viruses and plays a crucial role in the regulation of many cellular 
processes. In this project the activation of the PI3K/AKT signalling pathway and 
downstream processes such as apoptosis, translation and macropinocytosis were 
investigated during IBV infection. Techniques such as western blotting, 
immunofluorescence, flow cytometry and protein expression were used to determine 
the effect of IBV infection on modulation of the signalling pathway, as well as the 
downstream cellular effects of the modulation. This study demonstrates that IBV 
requires an active PI3K/AKT pathway for efficient replication, and that infection with 
IBV induces phosphorylation of AKT in a PI3K-dependent manner in mammalian 
and avian cells. This activation occurs late during infection in mammalian cells.  
However, in avian cells activation occurs in a biphasic manner at both an early and 
late time point during infection. To summarise the findings, a model is presented to 
describe the role of the PI3K/AKT signalling pathway during IBV infection.  
This study highlights the importance of the PI3K/AKT signalling pathway during IBV 
infection and may be applied to other human and livestock coronaviruses for 
development of therapeutics or novel vaccines.   
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1.1 The Poultry Industry and Avian Diseases 
Domestic chickens (Gallus gallus domestica) belong to the genus Gallus of the 
family Phasianidae and order Galliformes (Figure 1.1). Their closest relative is the 
red junglefowl (Gallus gallus) native to Asia, and present in Indonesia right through 
to China (Kan et al., 2010). There are 281 recognized species of game birds, 
divided amongst 81 genera, in the order Galliformes (Jourdan et al., 2012, 
Westneat, 1992). The current form of egg layer came about through years of 
domestication of the wild Red Junglefowl (Moiseyeva et al., 2003). In 2004, the 
chicken became the first agricultural animal and the first bird to have its genome 
sequenced (ICGSC, 2004). The genome of the chicken is less than half the size of a 
mouse at 1.07 Gb. It consists of 38 autosomes and 2 sex chromosomes referred to 
as Z and W, with the females carrying the ZW chromosomes (Figure 1.2). Their 
chromosomes vary much more in size than that of mammals, ranging from 200 Mb 
to 5 Mb (Romanov et al., 2009). The distribution of chicken breeds around the globe 
can be significantly attributed to human movement, as they lack the ability to fly or 
swim for long distances. This wide distribution highlights how important their trade 
has been throughout history. The British poultry industry itself produces around 875 
million chickens a year, in over 2,500 poultry farms across the UK (BPC, 2016). 
Poultry is the staple protein in the diet of many communities worldwide, where other 
forms of protein such as pork or beef may be prohibited by religion or law. It is 
because of this, and the relatively low production costs, that levels of consumption 
have been increasing yearly. Consumption of poultry has risen from 81 to 89 million 
metric tons in the last four years (FAS, 2012). Those numbers, when compared to 
the consumption of beef and veal at only 59 million metric tons, show how vital the 
poultry industry is.  
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The supply of poultry, to meet the ever-increasing demand, is often hindered by 
outbreaks of avian diseases. There are over 140 diseases and conditions that affect 
the poultry industry, with more than 12 of those being viral diseases (British Poultry 
Council, 2016). Amongst the most economically detrimental are Newcastle disease, 
Gumboro, and Avian Influenza (AI). As well as affecting the production of chickens, 
some viruses, such as Newcastle disease virus, are known to also infect turkeys, 
pigeons and geese. One avian viral disease of economic importance worldwide is 
Infectious Bronchitis. 
1.1.1 Infectious Bronchitis 
In 2005 the Department for Environment Food and Rural Affairs (DEFRA) 
commissioned a report in which Infectious Bronchitis (IB) was identified as being the 
most economically detrimental disease to the UK poultry industry (DEFRA, 2005). 
The disease was first described in 1931 in the USA and is currently endemic 
worldwide (Schalk and Hawn, 1931). Infectious Bronchitis is caused by the virus, 
infectious bronchitis virus (IBV), which is air-borne, spread by direct chicken to 
chicken contact or spread indirectly by mechanical means such as contaminated 
surfaces or drinking water. IBV is only known to naturally infect chickens and 
pheasants, where the infection establishes itself initially within the respiratory tract 
(Gough et al., 1977). Infection often leads to secondary bacterial infections, which 
contribute significantly to the pathology and rate of mortality (Vandekerchove et al., 
2004). However, the virus can spread to other organs such as the oviducts, where it 
interferes with egg production and laying (Cavanagh, 2007, Raj and Jones, 1997). 
As a result, IB commonly leads to a reduced level of egg laying and a decrease in 
egg quality (Crinion, 1972). Control of the disease involves the use of both live-
attenuated and inactivated vaccines. However, the large number of serotypes, poor 
cross-protection between the serotypes and the ability of the virus to mutate and 
recombine resulting in high levels of antigenic shift and drift, make vaccine 
programmes challenging (Cook et al., 2012).  
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1.2 Infectious Bronchitis Virus  
1.2.1 Virus classification – Coronaviridae  
The Coronavirinae sub-family is separated into four genera, the α-, β-, γ- and δ-
coronaviruses, devised based on sequence information of the antigenic 
relationships between the viruses. IBV is classed as a γ-coronavirus whereas 
SARS-CoV, and the recently emerged MERS-CoV are β-coronaviruses. The 
emergence of SARS- and MERS-CoV has attracted much attention to the 
Coronavirinae family. Both viruses are thought to have originated in bats (Li et al., 
2005, Wang et al., 2014b), before crossing into the human population through an 
intermediate host (Alagaili et al., 2014, Haagmans et al., 2014, Hemida et al., 2014, 
Wang and Eaton, 2007). The ability of coronaviruses to jump between species may 
be partly attributed to high sequence variation in the spike glycoprotein, a class 1 
fusion protein, which is largely responsible for the control of entry (Belouzard et al., 
2012).  
1.2.2 Genome organisation & Viral proteins 
IBV is a circular virion with spike-like projections from its membrane caused by the 
spike proteins. These give the virus, and other coronaviridae, the characteristic 
‘crown’, which can be seen in images taken by transmission electron microscopy 
(TEM), leading to the term ‘corona-virus’ (Figure 1.3). The basic structure of IBV can 
be seen in Figure 1.4A. The virus has three structural membrane proteins, the 
membrane (M) and envelope (E) and spike (S) proteins are embedded in the viral 
membrane. IBV S projects out to the exterior of the virion.  A schematic of the three 
transmembrane proteins, S, M and E can be seen in Figure 1.4B. The nucleocapsid 
protein (N) of IBV encloses a non-segmented, single-stranded, positive sense RNA 
genome of approximately 27kb (Figure 1.4A). A schematic of the genome is shown 
in Figure 1.5.  
Chapter 1 - Introduction 
 
Page | 28 
 
28 
 
 
 
  
Chapter 1 - Introduction 
 
Page | 29 
 
29 
  
Chapter 1 - Introduction 
 
Page | 30 
 
30 
ORF1a and 1b 
Gene 1 occupies approximately two-thirds of the genome and encodes two partially 
overlapping reading frames (open reading frame (ORF) 1a and 1b) at the 5ʹ-end of 
the genome. These encode the viral RNA polymerase and the replicase proteins as 
two large polyproteins. During synthesis the polyproteins are cleaved by virus-
encoded proteinases into 15 non-structural proteins (nsps) (Ziebuhr et al., 2000), 
which assemble at replication complexes. Whilst morphologically similar, β- and  γ-
coronaviruses differ in their genome composition. For example, the genome of β-
coronaviruses such as SARS-CoV encodes 16 non-structural proteins (nsps), 
whereas γ-coronaviruses, such as IBV, lack nsp1 and encode only 15 nps. The 
SARS-CoV nsp1 has been demonstrated to be involved in (Lokugamage et al., 
2012) host-translational shut-off. However, the 5b protein has been implicated in this 
role during IBV infection (Kint et al., 2016). Other nsps were found to be associated 
with the activation of cellular processes. For example, the nsp6 of IBV has been 
shown to induce autophagy during infection (Cottam et al., 2014). 
Spike Protein (S) 
Gene 2 encodes the S protein which is post-translationally cleaved into the N-
terminal S1 (92 kDa) and the carboyxl-terminal S2 (84 kDa). S is found in the viral 
envelope and projects out onto the surface of the virion. It is a type 1 
transmembrane protein consisting of a large ectodomain and short endodomain. 
The large ectodomain of the protein is divided into two subdomains, S1 with 
receptor binding properties, and S2 which contains the fusion machinery (Knipe and 
Howley, 2013). The S protein of coronaviruses is responsible for receptor binding 
and membrane fusion, and is therefore a critical determinant of tissue and cellular 
tropism (Casais et al., 2003). The first proteolytic cleavage site was found to be a 
furin cleavage site at the S1/S2 junction and is common amongst all IBV strains. A 
further site has been identified in S2, S2' (Belouzard et al., 2009). This second 
cleavage site is differentially cleaved between strains of IBV. The lab adapted strain 
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of IBV, Beau-R, acquired a mutation at its S2' site which is deemed ideal for furin 
recognition and cleavage (Casais et al., 2001). The presence of the second S2' 
cleavage site is thought to be the reason for the extended tissue and cellular 
tropism, characteristic of the Beau-R strain (Casais et al., 2004).  
Envelope Protein (E) 
The E protein is found embedded in the envelope and is a small 10 kDa protein with 
a single predicted hydrophobic domain (Ruch and Machamer, 2012). Coronavirus E 
proteins are generally present in low concentration in virions (Yu et al., 1994, Liao et 
al., 2006), however are abundant in infected cells where they are targeted to the 
Golgi and plays a role in assembly of new virions and budding (Liu and Inglis, 
1991a, Corse and Machamer, 2000, Corse and Machamer, 2002). IBV E also plays 
a role in modulating the secretory pathway by altering the luminal environments and 
re-arranging secretory organelles and host cell membranes such as the Golgi 
complex. This promotes viral replication and enables efficient trafficking of new 
virions. (Ruch and Machamer, 2011, Ruch and Machamer, 2012, Lavi et al., 1996).  
Accessory Proteins 3a & 3b 
As well as structural proteins, the IBV genome encodes at least four accessory 
proteins translated from two polycistronic mRNAs (Liu et al., 1991, Liu and Inglis, 
1991b, Liu and Inglis, 1992a, Liu and Inglis, 1992b). ORF 3a and 3b encode 
accessory proteins (Hodgson et al., 2006). The accessory proteins are small (50-
300 aa) proteins that are not essential for virus replication (Hodgson et al., 2006) 
(Narayanan et al., 2008). During infection with IBV the IFN response of infected cells 
is suppressed early during infection (Kint et al., 2015b), and the accessory proteins 
3a and 3b are involved in this resistance (Kint et al., 2015a).  
Membrane Protein (M) 
The structural membrane protein (M) is a transmembrane protein of between 25 and 
33 kDa. The M protein is found embedded within the envelope and has three 
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domains, a short N-terminal ectodomain, transmembrane domain and a C-terminal 
endodomain (Armstrong et al., 1984). In infected cells, M is localised primarily in the 
Golgi and interacts with both E and N proteins to assemble new virions (Neuman et 
al., 2011, Narayanan et al., 2000, Corse and Machamer, 2003, Siu et al., 2008, Lim 
and Liu, 2001, de Haan et al., 2000). The M proteins of other coronaviruses such as 
MHV and SARS-CoV have also been implicated in the process of budding (Tooze et 
al., 1984), (Siu et al., 2008). 
Accessory Proteins 5a & 5b 
IBV is unique among coronaviruses as it encodes two ORF’s, 5a and 5b, the 
proteins of which are not necessary for replication (Casais et al., 2005). The IBV 
accessory protein 5b has recently been implicated in host translational shutoff, 
where the production of host proteins is supressed and a selective increase in the 
production of viral proteins occurs (Kint et al., 2016).  
Nucleocapsid Protein (N) 
The coronavirus N protein is a soluble phosphoprotein with a molecular weight of ~ 
50 kDa, that is involved in many processes during replication (Emmott et al., 2013). 
These include packaging of viral RNA (Davies et al., 1981, Spencer and Hiscox, 
2006), acting as a chaperone for viral RNA, control of transcription, and the 
modulation of immune responses (Zúñiga et al., 2010).  
A final 3ʹUTR is present downstream of gene 6 which is highly conserved among 
different strains of IBV (Collisson et al., 1990). 
In 2001 a reverse genetics system was developed for IBV that allowed the 
generation and manipulation of full-length genomic cDNAs of the viral genome 
(Casais et al., 2001). These full-length cDNAs were cloned into the vaccinia virus 
genome and recombinant IBV was recovered after in situ synthesis of IBV RNA 
using the bacteriophage T7 RNA polymerase expressed from recombinant fowlpox 
virus. The development of the reverse genetics system has enabled research into 
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various aspects of the biology of IBV infections. For example, the system was used 
to investigate the importance of the S protein in cellular tropism, pathogenicity and 
immunogenicity (Casais et al., 2003, Hodgson et al., 2004) 
1.2.2 Viral pathogenesis  
Infectious bronchitis virus initially infects the respiratory tract where it can be 
detected in epithelial cells of the trachea and lung (Hofstad and Yoder, 1966, Ambali 
and Jones, 1990, Lee et al., 2002, Meir et al., 2004). The highest levels of tissue 
infection were seen at 2 dpi but were lower by 5 dpi. Accordingly, viral titres were 
maximal in the nose and trachea within 3 dpi and were high for a further two to five 
days (Ambali and Jones, 1990). In addition to respiratory organs, several strains of 
IBV have been isolated from the cecal tonsils, lymphoid organs that elicit protective 
immunity against pathogens in the intestinal tract, and the kidneys (Benyeda et al., 
2009, Lucio and Fabricant, 1990, Terregino et al., 2008, Ganapathy et al., 2012). 
These include the IBV strain, M41, which is neuropathogenic and causes mortality 
(Cook et al., 2001). Some strains of IBV has also been detected in the testes (Boltz 
et al., 2004) and ovaries (Zhong et al., 2016), where infection causes reduced 
fertility and egg laying.  
The host and viral determinants of IBV pathogenicity are still not fully understood. 
The disease is characterised by increased oculonasal secretion and excess of 
mucus in the trachea. It supresses weight gain and where the virus also replicates in 
the oviduct, reduces egg production. The severity of disease has often been 
measured by investigating levels of ciliostasis in tracheal sections (Donnelly et al., 
1974). The cilia and mucociliary apparatus of the respiratory tract allow for 
protection against pathogens. However, during IBV infection, the cilia of the trachea 
cease to move and slough off from the trachea. Recently, a study has identified a 
possible link between levels of apoptosis induced during infection and disease 
(Chhabra et al., 2016). In particular, the study demonstrated that infection of primary 
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embryonic kidney cells, with strains of IBV that predominantly cause nephritis (e.g. 
QX), resulted in higher levels of apoptosis compared to M41, which primarily causes 
respiratory lesions. This up-regulation of apoptosis was also coordinated with an up-
regulation of TLR3, MDA5 and IFN-β in chick kidney cells during infection with QX, 
compared to M41. These results were reversed in tracheal organ cultures (TOCs) 
where M41 infection resulted in an up-regulation in the immune-modulatory genes, 
and QX did not. It was therefore hypothesised that the host innate immune 
response, and in particular apoptosis, is a key determinant of pathogenicity during 
IBV infection (Chhabra et al., 2016).  
 1.2.3 Viral Replication 
A schematic of generalised coronavirus replication is shown in Figure 1.6. 
Viral Entry 
IBV entry into the host cell is less well characterised than other coronaviruses.  To 
initiate entry, the coronavirus S glycoprotein mediates attachment to the host cell 
receptors. The cellular receptors vary between different coronaviruses. For example, 
α-coronaviruses, such as the feline coronavirus and the human coronavirus 229E, 
bind to aminopeptidase N on the cell surface (Tresnan et al., 1996, Yeager et al., 
1992). The cellular receptors for β-coronaviruses are varied, with SARS-CoV 
binding to angiotensin-converting enzyme 2 (Li et al., 2003), and MHV binding to 
carcinoembryonic antigen-related cell adhesion molecule 1 (Williams et al., 1991). 
However, other β-coronaviruses such as bovine coronavirus and porcine 
hemagglutinating encephalomyelitis virus recognise and bind to sialic acids on the 
cell surface such as N-acetyl-9-O-acetylneuraminic acid (Vlasak et al., 1988, 
Schultze and Herrler, 1992, Schultze et al., 1990). The cellular receptors for γ-
coronaviruses such as IBV have not been fully characterised. However, IBV is 
known to bind to α2,3 linked sialic acids on the cell surface, but it is not known if this 
is the only factor involved (Winter et al., 2006) (Promkuntod et al., 2014). 
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 When S1 binds to the receptor, conformational changes are induced in the spike 
protein, which lead to viral-cell fusion and release of the nucleocapsid into the 
cytoplasm (Bonavia et al., 2003). In the case of SARS-CoV and the MHV strain A59, 
the virus enters the cell via the clathrin-dependent endocytosis pathway, before 
being transported to early endosomes where entry is pH-dependent (Inoue et al., 
2007, Yang et al., 2004a, Eifart et al., 2007). The exact mechanism by which IBV 
enters the cell is unknown. Patterson et al (1976) observed IBV entry by electron 
microscopy and determined that entry did not occur by fusion of viral and cellular 
plasma membranes and instead suggested uptake via an endocytic pathway. Chu et 
al., (2006) also observed PH-dependent fusion of the viral and cellular membranes 
and this is now the accepted theory.  
Viral replication and protein synthesis 
The viral mRNA is recognised by host machinery due to the presence of a 5ʹ-cap 
and 3ʹ-polyA tail on the viral mRNA. Once inside the cytoplasm, viral genomic RNA 
acts as mRNA for the translation of the replicase polyproteins pp1a and pp1ab in the 
cytoplasm. The virus encoded proteases, nsp3 and nsp5, proteolytically cleave the 
replicase polyproteins into 15 non-structural proteins. The expression of viral 
replicase proteins results in the rearrangement of cellular membranes to assemble 
viral replication complexes in the majority of positive-strand RNA viruses. The types 
of membrane rearrangements formed range from single-membrane or double-
membrane vesicles to convoluted membranes and small membrane invaginations 
called spherules (Blanchard and Roingeard, 2015). The replication proteins of 
positive-strand RNA viruses are often found within these membranes and therefore 
the replication complexes are likely to be associated with these membrane 
rearrangements. For example, replication of poliovirus results in the formation of 
double-membrane vesicles that form from single-membrane vesicles possibly 
originating from Golgi membranes (Schlegel et al., 1996). The outer membrane of 
both the single- and double-membrane vesicles is the location of poliovirus replicase 
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proteins and nascent viral RNA (Belov et al., 2012). The formation of membrane re-
arrangements has also been investigated during some coronavirus infections. 
SARS-CoV and MHV induce double-membrane vesicles derived from the ER 
(Knoops et al., 2008, Ulasli et al., 2010). Connected to the double-membrane 
vesicles is a series of convoluted membranes also derived from the ER. The 
coronavirus replicase proteins are commonly found on both structures. The 
formation of membrane re-arrangements during IBV infection has recently been 
investigated by Maier et al. (2013b). In addition to double-membrane vesicles, 
infection of cells with IBV was found to induce the formation of novel structures 
termed zippered-ER, which were associated with small spherules. The spherules 
were connected to the zippered-ER and contained a channel with a diameter large 
enough to facilitate the movement of nucleotides and RNA structures. These 
structures had not previously been reported in coronavirus infections and are 
hypothesised to be the site of IBV replication.  
All viruses of the Nidovirales order employ sub-genomic mRNA (sgRNA) to mediate 
expression of structural and accessory proteins. In particular the corona- and 
arteriviruses employ a discontinuous method of RNA synthesis (Lai & Cavanagh, 
1997). Downstream of the replicase gene, the IBV genome encodes for structural 
and accessory proteins that are expressed from a set of at least five nested mRNAs 
(Sawicki et al., 2007, van Vliet et al., 2002). Each of these sgRNAs contain a 
common leader sequence, derived from the 5ʹ terminus of the viral genome (van der 
Most and Spaan, 1995). The leader and coding sequences are joined by a 
transcription-regulating sequence (TRS) which is an important factor in sgRNA 
synthesis (Makino et al., 1991, van der Most et al., 1994, Zhang and Lai, 1994). The 
N protein of IBV is known to associate with the genomic RNA to form the 
nucleocapsid that is incorporated into new virions (Klumperman et al., 1994). 
Chapter 1 - Introduction 
 
Page | 38 
 
38 
Assembly of new virions and exit from the cell 
The viral structural proteins assemble and bud into the lumen of the ER-Golgi 
intermediate compartment (ERGIC) to form new virions (Krijnse-Locker et al., 1994). 
Virus particles then bud off from the Golgi and exit the cell by exocytosis (Tooze et 
al., 1987). The E, M and S proteins of IBV have all been implicated in the assembly 
of new virions and exit from the cell. The IBV E protein has been found to direct the 
release of virus-like particles from the Golgi (Corse and Machamer, 2000). Ruch and 
Machamer (2011) also demonstrated that when the transmembrane domain (TM) of 
IBV E was replaced with a non-oligomerizing TM domain of the vesicular stomatitis 
virus glycoprotein (VSVG), infectious virus particles were not released. Therefore, 
suggesting a role for IBV E in budding. The interaction of E and M proteins has been 
found to produce virus-like particles that are similar in size and shape to IBV virions 
(Corse and Machamer, 2002). The IBV S protein, when expressed alone has 
recently been found to accumulate near the virus assembly site (Lontok et al., 
2004). It was also found to contain trafficking signals such as the ER retrieval signal, 
and a tyrosine-based endocytosis signal. Studies with IBV S-mutants lacking the 
endocytosis signal were not able to replicate (Youn et al., 2005).  New virions are 
seen to be released from 6 hpi in cell culture. Whilst the replication cycle of IBV is 
non-lytic, cytopathic effect (CPE) is observed in IBV infected cells from 24 hpi.  
1.3 PI3K/AKT signalling  
1.3.1 AKT Isotypes 
AKT, also known as protein kinase B (PKB) is a protein kinase that plays a critical 
role in the regulation of cell growth and survival. It has most notably been implicated 
in many forms of cancer such as thyroid cancer (Saji and Ringel, 2010), kidney 
cancer (Porta and Figlin, 2009) and prostate cancer (Shukla et al., 2007). AKT was 
first identified as a homolog of the retroviral oncogene viral AKT (v-AKT) (Bellacosa 
et al., 1991), and has since been categorised as a member of the AGC kinase 
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family. Members of the AGC kinase family, such as Protein Kinase C (PKC) and 
Phosphoinositide-dependent Protein Kinase 1 (PDK-1), share a homologous 
catalytic domain. The family consists of approximately 60 members that are 
phosphorylated at a serine (S) or threonine (T) residue (Fayard et al., 2005). These 
phosphorylation sites occur primarily close to lysine or arginine residues.  
The PH (Pleckstrin-homology) domain, catalytic domain and the regulatory domain 
are all well conserved between AKT isotypes. In mammals there are three isotypes 
of AKT, AKT1, AKT2 and AKT3 (Figure 1.7). The PH domain of AKT is located at 
the N terminus and is conserved between other signalling molecules that bind 
phosphoinositides. The catalytic domain or kinase domain is situated in the centre of 
the protein and is the site of phosphorylation at T308 (in human AKT1). The 
regulatory domain is at the C-terminus of the protein and contains an amino acid 
sequence (F-P-Q-F-S-Y) which is conserved among the AGC kinase family in most 
mammalian isoforms. The regulatory domain of the kinase is also the location of the 
S473 phosphorylation site (in human AKT1). Whilst the mammalian isoforms have a 
high level of homology, studies using AKT knockout mice have documented 
phenotypic differences in their functions. The effect of deletion of the mammalian 
AKT1 gene has been investigated in mutant mice (Yang et al., 2004b).  Upon 
examination of the development of embryos in the uterus it was found that deletion 
of AKT1 affected both placental development and animal growth (Cho et al., 2001b). 
Deletion of AKT2 induced severe diabetes in knockout mice, indicating a role for the 
isotype in insulin signalling (Cho et al., 2001a). The tissue distribution of AKT2 also 
illustrates its role in glucose homeostasis, with it being found in high abundance in 
insulin-responsive organs and tissues such as the liver and skeletal muscle (Yang et 
al., 2003). The role of the AKT3 gene in the postnatal development of the brain was 
identified in AKT3 knockout mice. AKT3 mutant mice exhibited reduced brain size 
and weight, suggesting that AKT3 is an important factor in brain development (Yang 
et al., 2004b).                
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1.3.2 PI3K/AKT mammalian signalling pathway 
AKT plays an integral part in many cellular processes including cell growth, cell 
death and protein synthesis. In most cases AKT works as part of the 
phosphoinositide-3 kinase (PI3K)/AKT signalling pathway where it is activated 
indirectly by PI3K, a membrane bound kinase (Figure 1.8). However, AKT can also 
be activated independently of PI3K, by PKA (cyclic AMP-dependent protein kinase) 
(Sable et al., 1997, Mahajan and Mahajan, 2012, Yoganathan et al., 2000, Persad et 
al., 2000, Yano et al., 1998), but will not be described here. Figure 1.8 shows the 
PI3K signalling pathway upstream of AKT activation.  
Growth factors such as the platelet-derived growth factor (PDGF), epidermal growth 
factor (EGF), fibroblast growth factor (FGF) and the insulin-like growth factor 1 (IGF-
1) bind to receptors on the surface of the cell.  These receptors are often G-protein 
coupled receptors which then activate class I PI3Ks (Hawes et al., 1996). Class I 
PI3Ks are heterodimeric enzymes that contain a regulatory p85 subunit along with 
an enzymatic p110 subunit (Vanhaesebroeck et al., 1997). The majority are coupled 
to extracellular receptors and are therefore found at the plasma membrane. 
However, they are also present at the nuclear membrane along with AKT (Neri et 
al., 2002).  Activation of PI3K leads to the phosphorylation of PIP2 
(Phosphatidylinositol 4,5-bisphosphate) into PIP3 (Phosphatidylinositol 3,4,5-
trisphosphate) and recruitment of AKT to plasma membrane. PI3K/AKT signalling 
can be inhibited by inhibition of PI3K activity using the small molecule inhibitor 
LY294002 (Vlahos et al., 1994). The pathway can also be inhibited at this step by 
PTEN, which actively dephosphorylate PIP3 (Maehama and Dixon, 1998). The PH-
domain of AKT facilitates the interaction between itself and PIP3 (Thomas et al., 
Bellacosa et al., 1998). Once bound, a conformational change occurs in AKT 
allowing phosphorylation at T308 by PDK1 (Stephens et al., 1998, Andjelkovic et al., 
1997, Alessi and Cohen, 1998). When a PH-domain deletion mutant of AKT was 
used, PIP3 was not required for phosphorylation at T308 (Biondi et al., 2000).  
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For complete activation, phosphorylation at the S473 is also required (Alessi et al., 
1996). Phosphorylation at S473 does not occur via the PDK1 pathway (Williams et 
al, 2010). Instead, it is facilitated by direct interaction with mTORC2 (mammalian 
target of rapamycin complex 2) (Sarbassov et al., 2005). Activation of AKT at T308, 
but not S473, allows the kinase to activate some, but not all, of its substrates 
(Guertin et al., 2006).  
After activation at the plasma membrane, the kinase translocates to cellular 
compartments such as the ER (Boulbes et al., 2011), mitochondria, Golgi (Du et al., 
2006) and nucleus (Andjelkovic et al., 1997).  
All downstream targets of AKT contain an AKT consensus sequence (R-X-R-X-X-
S/T). These include FOX01 and Bad involved in cell survival, GSK3-β, involved in 
cell cycle and glycogen synthesis and 4E-BP1 involved in cap-dependent 
translation. Some of the pathways activated downstream of PI3K/AKT signalling are 
presented in Figure 1.9. The role of the PI3K/AKT signalling pathway in many 
cellular processes makes it a prime target for control by viruses to aid viral 
replication and subvert anti-viral responses.  
1.4 Viral modulation of cellular signalling 
As obligate intracellular parasites, all viruses are able to subvert cellular machinery 
during their life cycle to create an environment that is favourable for virus replication. 
The earliest point at which the host cellular pathways are activated is during initial 
attachment and entry of the virus into the cell. The attachment and invasion of the 
virus into the cell elicits cellular anti-viral responses. Binding of viral proteins to host 
receptors also initiates signalling cascades that begin to establish a favourable 
environment for the virus within the cell. For example, within a minute after exposure 
with HIV-1 more than 200 phosphorylation sites are modified in T-cells, the majority 
of which are involved in pro-viral processes such as alternative splicing and cell 
survival (Wojcechowskyj et al., 2013).  
A 
C B 
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The binding of influenza A virus (IAV) to the sialic acid receptor of the host cell, 
results in clustering of plasma membrane lipid rafts that are thought to be involved in 
signal transduction (Lakadamyali et al., 2004). Attachment of IAV to the cell also 
leads to the activation of at least two receptor-tyrosine kinases and signalling 
through the PI3K/AKT signalling pathway to promote viral internalisation (Eierhoff et 
al., 2010). 
1.4.1 Viral replication and protein synthesis 
Many viruses take advantage of pre-mRNA splicing to produce different transcript 
isoforms and increase proteomic diversity in the virus. The usage of alternative 
splice sites is regulated by splicing factors such as serine arginine rich proteins (SR) 
which bind to cis-regulatory elements near the splice sites. HIV-1 was found to 
mediate phosphorylation of SR proteins through the PI3K signalling pathway, as 
inhibition of PI3K results in an altered splicing pattern of HIV-1 mRNAs as well as a 
significant reduction in viral replication (Hillebrand et al., 2014). 
The modulation of AKT activation controls translation of mRNA via the mTOR 
signalling pathway. During translation of host mRNA the cap-binding protein eIF4E 
recognises the 7-methyl guanine cap structure at the 5ʹ end (5ʹ-cap) of the mRNA. 
The eIF4E, together with eIF4G and the eIF4A helicase, form the eIF4F initiation 
complex. This complex facilitates unwinding of the mRNA and attachment to the 40s 
ribosomal subunit. The formation of the eIF4F complex can be blocked by the 
binding of 4E-BP (eIF4E-binding protein) to eIF4E (Figure 1.10). The rate limiting 
step in the process of mRNA translation is the binding of the mRNA to the ribosomal 
subunit which is facilitated by the binding of eIF4E to the 5ʹ-cap of mRNA 
(Khaleghpour et al., 1999). The binding of hypo-phosphorylated eIF4E binding-
proteins (4E-BPs) can inhibit this process and therefore control translation (Mader et 
al., 1995). The phosphorylation of 4E-BPs results in the inability of the proteins to 
bind to eIF4E, allowing the initiation of translation.   
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This phosphorylation is modulated by the PI3K/AKT/mTOR signalling pathway 
(Miron et al., 2003). Some viruses therefore induce dephosphorylation of 4E-BPs to 
impair cellular translation (Gingras et al., 1996, Connor and Lyles, 2002). The 
PI3K/AKT/mTOR signalling cascade also modulates translation through activation of 
the p70-S6 Kinase 1 (S6K1) (Figure 1.11). Several substrates of S6K1 have been 
identified and are involved in the initiation of translation. Primarily S6K1 induces the 
phosphorylation and activation of the S6 protein which forms part of the 40s 
ribosomal subunit. In addition, S6K1 activation also induces phosphorylation of 
eIF4B and the eEF2 kinase. Phosphorylation of the eEF2 kinase inhibits its activity, 
which in turn allows the translocation of tRNA from the A site to the P site of the 
ribosome. As well as modulation of 4E-BP and S6K1, phosphorylation of eIF4E itself 
can modulate its activity. The mitogen-activated protein kinase interacting kinases 
(Mnk1/2) phosphorylate eIF4E at S209 (Waskiewicz et al., 1997). Some viruses, for 
example the murine norovirus 1, have been shown to control translation by 
modulation of eIF4E phosphorylation directly (Royall et al., 2015). 
Many viruses employ the host shutoff mechanism, involving the suppression of host 
translation and protein synthesis, thereby preventing antiviral host responses. The 
influenza virus NS1 protein, for example, has been implicated in the suppression of 
host mRNA translation (Nemeroff et al., 1998, Noah et al., 2003). Host shutoff is 
often coupled with the selective translation of viral mRNA, as some viruses employ 
unique strategies to enable translation of viral mRNA. The initiation of viral mRNA 
translation by most picornaviruses take place at internal ribosome entry sites 
downstream of the 5ʹ-end, and therefore occurs in a cap-independent manner 
(Sweeney et al., 2014, Ochs et al., 1999). Other viruses, such as members of the 
Caliciviridae family, employ a viral genome-linked protein (VPg) that is attached to 
the 5ʹ-end of both genomic and sgRNAs (Herbert et al., 1997, Schaffer et al., 1980).  
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Binding of the VPg to eIF4E allows for translation of viral mRNA (Daughenbaugh et 
al., 2003, Goodfellow et al., 2005, Chung et al., 2014).   
1.4.2 Viral replication and cell survival 
Apoptosis was first described in 1972 (Kerr et al., 1972) and an understanding of the 
mechanisms involved were initially formed from studies of programmed cell death in 
Caenorhabditis elegans (Ellis and Horvitz, 1986). Apoptosis naturally occurs as a 
homeostatic mechanism allowing cell populations to be maintained in tissues. It is 
induced in different cell types in different ways. For example, some cells express 
Fas or TNF receptors that allow ligand binding to induce apoptosis. Whereas, other 
cells have a constitutively active pro-apoptotic pathway that must be blocked by 
survival factors such as growth factors or hormones.  
There are two known apoptotic pathways, the extrinsic and intrinsic pathway (Figure 
1.12). Both pathways are interconnected and it is thought that there is a level of 
cross-signalling between them (Igney and Krammer, 2002). The extrinsic apoptotic 
pathway is initiated by activation of death receptors, members of the TNF receptor 
gene superfamily (Locksley et al., 2001). Death receptors are activated by their 
ligands at the cell surface and transmit the pro-apoptotic signal into the cell 
(Ashkenazi and Dixit, 1998, Schulze-Osthoff et al., 1998). This promotes recruitment 
of cytoplasmic adapter proteins to the cell surface where they bind with the death 
receptors. For example, the Fas receptor (Nagata and Golstein, 1995) is known to 
be activated by the Fas ligand (Itoh and Nagata, 1993) which promotes recruitment 
of the FADD (Fas-associated protein with death domain) adapter proteins to the 
cellular membrane which contains a FasR binding domain (Yonehara et al., 1989). 
Once bound to the death receptor, the adapter protein, e.g. FADD, associates with 
procaspase-8. This forms a death-inducing signalling complex (DISC) resulting in 
the activation of casapse-8 (Kischkel et al., 1995). Once activated, caspase 8 
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triggers a pro-apoptotic signalling cascade through caspase 3 (Stennicke et al., 
1998).  
The intrinsic apoptotic pathway also initiates apoptosis through caspase 3 signalling. 
This pathway is often modulated by PI3K/AKT signalling and the absence of a pro-
survival signal (Bonni et al., 1999). For example, the absence of certain growth 
factors, cytokines and hormones may prevent activation of the anti-apoptotic 
PI3K/AKT signalling, therefore failing to supress the apoptotic response (Yao and 
Cooper, 1995, Kauffmann-Zeh et al., 1997, Kulik et al., 1997). The subsequent pro-
apoptotic signal induces changes in the mitochondrial membrane and the release of 
cytochrome c through Bad and Bax signalling (Kennedy et al., 1999, Yamaguchi and 
Wang, 2001, Wei et al., 2001). Cytochrome c then binds and activates Apaf-1 and 
caspase-9 forming an apoptosome (Cain et al., 2002) (Chinnaiyan, 1999, Shiozaki 
et al., 2002). Activated caspase-9 acts as an initiator caspase to activate caspase-3 
(McDonnell et al., 2003). The crucial role of this caspase in both apoptotic pathways 
means that activation of caspase 3, and also caspase 7, are good markers for 
measuring apoptotic signalling (Chen et al., 2015). Caspase 3 activates the 
endonuclease CAD (caspase-activated deoxyribonuclease), which degrades 
chromosomal DNA in the nuclei and causes the characteristic chromatic 
condensation (Enari et al., 1998). The activity of caspase 3 also induces cytoskeletal 
reorganisation and formation of apoptotic bodies (Kothakota et al., 1997). The 
externalisation of phosphatidylserine (PS) on the surface of apoptotic cells then 
triggers phagocytic uptake of the cell (Fadok et al., 1992). Like caspase 3 and 7 
activation, the externalisation of PS is also an indicator of apoptosis and can be 
measured by using fluorescently labelled Annexin V that binds specifically to 
externalised PS (Tait et al., 2004, Andree et al., 1990, Huber et al., 1990).  
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Whilst apoptosis naturally occurs in order to maintain homeostasis, it is also 
employed as a defence mechanism during immune reactions or cell damage 
(Norbury and Hickson, 2001). During viral infection regulation of apoptosis can result 
in pro-viral or anti-viral responses (Koyama et al., 1998). For example, induction of 
apoptosis by cells early during viral replication may prevent replication and release 
of new virions, thereby preventing spread of the virus to neighbouring cells. In these 
cases, the virus may also act to prevent apoptosis by activating anti-apoptotic 
pathways such as the PI3K/AKT signalling pathway. The SARS-CoV E protein, for 
example, has been found to have anti-apoptotic effects and its deletion reduces the 
pathogenicity and mortality in model animals. (DeDiego et al., 2011, DeDiego et al., 
2014). Conversely, some viruses require apoptosis to complete replication activation 
(Tran et al., 2013). Viruses that have a lytic replication cycle may induce apoptosis 
by inhibiting the anti-apoptotic signalling pathways, thereby allowing the release of 
new virions during breakdown of the cell or uptake of the virus by phagocytic cells. 
There is often a delicate interplay between pro-apoptotic and anti-apoptotic 
signalling. Influenza A virus (IAV) infection triggers apoptosis (Takizawa et al., 1993, 
Fesq et al., 1994, Mori et al., 1995). During IAV infection the virus uses the apoptotic 
pathway to promote activation and exportation of the viral RNP complex from the 
nucleus to the cytoplasm (Wurzer et al., 2003, Chen et al., 2001). However, 
apoptosis is also known to be involved in the clearance of IAV infected cells and 
therefore the elimination of infection (Chang et al., 2015). The NS1 protein of IAV 
also activates NF-kB through the activation of the PI3K/AKT signalling pathway to 
inhibit apoptosis and increase cell viability (Zhirnov et al., 2002, Zhirnov and Klenk, 
2007).   
Apoptosis also occurs as a result of ER stress (Liao et al., 2013). The unfolded 
protein response (UPR) is initiated when the ER is overloaded and proteins are mis-
folded and accumulate causing stress to the ER. The UPR is a cellular survival 
response that is initiated by several sensors (Ron and Walter, 2007). Investigation 
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into the pathway upstream of UPR has identified three important proteins to date, 
the protein kinase R-like ER kinase (PERK) (Harding et al., 1999, Harding et al., 
2000), activating transcription factor 6 (ATF6) (Haze et al., 1999, Lee et al., 2003) 
and inositol-requiring enzyme 1 (IRE1) (Calfon et al., 2002, Yoshida et al., 2001). 
PERK, ATF6 and IRE1 are activated sequentially to induce the UPR which inhibits 
the synthesis of new proteins and induces degradation of mis-folded proteins 
therefore relieving ER stress. PERK is instrumental in the inhibition of translation 
(Harding et al., 1999). Activated by self-phosphorylation, it phosphorylates eIF2α 
and stabilises the eIF2-Dp-eIF2B complex thereby inhibiting the formation of the 
43S initiation complex and subsequent protein synthesis (Bollo et al., 2010). 
Phosphorylation of eIF2α also results in the enhanced selective translation of the 
activating transcription factor (ATF4) which activates genes involved in metabolism, 
oxidative stress and apoptosis (Harding et al., 2000). In this way the UPR is able to 
re-establish homeostasis and prevent cell death, however, if prolonged ER stress 
occurs or the ER is damaged, the UPR may be prolonged and induce apoptosis (Lin 
et al., 2007).  
The effect of IBV on ER-stress induced apoptosis has been investigated by Liao et 
al, (2013). The role of PERK and PKR in the induction of eIF2α activation has been 
identified during IBV infection. In mammalian Vero cells, eIF2α was found to be 
activated early during viral replication at between 2 and 8 hpi but to decrease from 8 
hpi. Phosphorylation of eIF2α by PKR restricts the activity of eIF2B to form tRNA 
ternary complexes. This stalls translation and the accumulating tRNA complexes 
form stress granules in the cytoplasm of infected cells. Phosphorylation of PERK 
was also seen early during IBV infection, suggesting that ER stress may be induced 
early during IBV infection and that the UPR response may be triggered to inhibit 
protein translation but selectively promote translation of ATF4 to induce apoptosis.  
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1.4.3 Viral replication and macropinocytosis 
Macropinocytosis, first described in 1931 (Lewis, 1931), can be defined as the bulk 
uptake of fluid or extracellular components into the cell. It is a clathrin-independent 
process that is dependent on signals originating as a response to growth factors 
such as EGF or tumour-promoting factors such as PMA (Phorbol myristate acetate) 
(Nakase et al., 2015). Macropinocytosis can be identified primarily as it causes 
ruffling of the plasma membrane (Ridley, 1994) (Figure 1.13). Many lamellipodia fold 
back in on themselves to fuse with the plasma membrane, creating large 
macropinosomes (Lim and Gleeson, 2011). Whilst the size of macropinosomes is 
not consistent, they are generally considered to be more than 0.2 µm in diameter 
and are considerably larger than micropinosomes and clathrin-coated vesicles 
(Conner and Schmid, 2003, Kerr and Teasdale, 2009). These macropinosomes 
allow the intake of large amounts of nutrients into the cell (Lim and Gleeson, 2011). 
However, the membrane ruffling associated with macropinocytosis has also been 
implicated in cell motility (Kerr and Teasdale, 2009). 
Macropinocytosis is known to be regulated downstream of PI3K as treatment with 
PI3K inhibitors reduces fluid phase uptake via macropinocytosis (Veithen et al., 
1998, Amyere et al., 2000). Recently a model for macropinocytosis signalling has 
been proposed involving the recruitment of sorting nexins (Kerr et al., 2006, Lim et 
al., 2008). A direct relationship between the amount of cell surface SNX5 protein 
and macropinocytic activity has been seen (Lim et al., 2008). It was suggested that 
the pathway is modulated by the SNX5 (sorting nexin protein 5) which binds 
preferentially to PIP2. The EGF receptor, and subsequently PI3K, is thought to be 
activated triggering the production of PIP3. A 5ʹ-phosphatase then generates PIP2 
from PIP3. 
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 Presence of elevated levels of PIP2 recruits SNX5 to specific areas of the plasma 
membrane where macropinocytosis is seen to occur. SNX5 may be involved in the 
deforming of the membrane allowing the formation of macropinocytic pit which then 
buds off from the cytosolic surface of the plasma membrane (Wang et al., 2010, 
Carlton et al., 2004, Peter et al., 2004). 
 Macropinocytosis is often modulated to allow uptake of pathogens into the cell. 
Amongst these are protozoa such as the parasite Leishmania (Wanderley et al., 
2006) and bacteria such as Salmonella (Garcia-Perez et al., 2003) and Legionella 
(Watarai et al., 2001). The pathway is modulated more frequently however by 
viruses (Mercer and Helenius, 2012, Mercer and Helenius, 2009, Mercer et al., 
2010). Viruses that use macropinocytosis to enter the cell include, vaccinia (Mercer 
et al., 2010), HIV-1 (Maréchal et al., 2001), adenovirus (Amstutz et al., 2008) and 
Ebolavirus (Aleksandrowicz et al., 2011, Saeed et al., 2010). The vaccinia virus, for 
example, envelopes itself in the membrane of a dying infected cell, thereby 
mimicking a cell undergoing apoptosis (Mercer and Helenius, 2008). When the virus 
is then presented to a healthy cell, large transient membrane blebs are formed, in 
which the virus is thought to be taken up. Recently, a role for micropinocytosis in 
several coronavirus infections has been suggested. Freeman et al., (2014) identified 
macropinocytic activity in MHV and SARS-CoV infected cells late during infection. 
They also noted that the coronavirus-induced macropinocytosis occurred 
independently of virus entry. 
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1.5 Aims and Objectives 
The aim of this study was to investigate the role of the PI3K/AKT signalling pathway 
during infection with avian infectious bronchitis virus. To investigate this role, several 
objectives were established.  
Objective 1 
The first objective was to identify the magnitude and duration of AKT activation in 
IBV infected cells. Studies of avian viruses are often conducted in mammalian cells 
due to lack of reagents and established protocols. It was therefore decided that the 
activation of AKT be investigated in both mammalian and avian cells. This would not 
only allow the development of protocols in avian cells, but also allow for 
comparisons in the interaction of the virus with the two cell lines.  
Objective 2 
The second objective of this study was to investigate the downstream effects of 
PI3K/AKT signalling on IBV replication, cellular proteins synthesis, apoptosis and 
macropinocytosis.  
Objective 3 
In addition, the mechanisms by which the virus induces PI3K/AKT signalling and 
modulation of downstream processes were to be investigated. 
Objective 4  
The fourth objective was to determine the localisation and expression levels of avian 
AKT isoforms in avian tissues. This included a bioinformatic investigation into the 
location of the avian AKT2 gene.  
Objective 5 
Furthermore, the effect of IBV infection on the expression of avian AKT1 and AKT3 
was to be investigated in avian cells and tissues. 
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2.1 Materials 
2.1.1 General chemicals and enzymes 
Unless stated otherwise, all chemical reagents and enzymes were purchased from 
New England Biolabs (NEB), Roche, GE Healthcare, Invitrogen, Sigma-Aldrich, 
Stratagene and Promega.  
2.1.2 Antibodies 
Unless stated otherwise all antibodies were purchased from Cell Signalling 
Technology or Abcam (Table 2.1). 
 
2.1.3 Oligonucleotides 
Synthetic DNA oligonucleotides were purchased from Sigma-Aldrich. AKT1 and 
AKT3 primers and hydrolysis probes were designed by and purchased from Primer 
Design UK Ltd.  
2.1.4 Cell lines 
Cell stocks were maintained by The Pirbright Institute Central Services Unit. All cell 
lines were maintained at 37 °C and 5% CO2.  
Chick Kidney (CK) cells: Primary chick kidney cells were prepared by 
trypsonization of the kidneys of 2-3 week old specific pathogen free (SPF) Rhode 
Island Red chickens (Hennion and Hill, 2015).  
DF1 cells: Continuous fibroblast cell line originating from the spontaneous 
transformation of fibroblasts from 10 day old embryos of East Lansing line chickens 
(Himly et al., 1998).  
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Vero cells: Continuous kidney epithelial cell line originating from the African Green 
monkey. 
2.1.5 Cell culture media 
Minimum Essential Medium (MEM), Dulbeccos Minimum Essential Medium (DMEM) 
and Foetal Calf Serum (FCS) were all purchased from Sigma-Aldrich. Phosphate 
Buffered Saline A (PBSa) was provided in-house by The Pirbright Institute Central 
Services Unit.  
CK cells were grown in CK growth media (Table 2.2) 
CK cells were maintained in 1x BES media (Table 2.3). 
DF1 cells were maintained in DMEM growth media (Table 2.4). 
Vero cells were maintained in EMEM growth media (Table 2.5). 
2.1.6 Virus 
M41-CK: Pathogenic strain of IBV adapted to grow in CK cells (Darbyshire et al., 
1979). 
IBV Beau-R: Beau-R is a molecular clone of the Beaudette-CK (Beau-CK) strain of 
IBV (Casais et al., 2001). It was adapted to grow in CK cells by multiple passages in 
embryonated eggs. Wider host range than M41-CK with the ability to replicate in 
mammalian Vero cells.  
IBDV: Infectious bursal disease virus was kindly donated by Dr Andrew Broadbent, 
The Pirbright Institute.  
2.1.7 Plasmids 
The pcDNA 3.1- S protein expression plasmid was provided by Phoebe Stevenson-
Leggett, Avian Endemic Viruses, The Pirbright Institute. 
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The pCI-neo-N protein expression plasmid was provided by Julian Hiscox 
(University of Liverpool) (Hiscox et al., 2001). It contains the Beau-CK N gene 
inserted into pCi-Neo. Expression is under the control of both the cytomegalovirus 
RNA polymerase II promoter and the T7 RNA polymerase promoter.  
Construction of plasmids for the expression of IBV-Envelope (pcDNA3.1-E) and IBV-
Membrane (pcDNA3.1-E-FLAG) is described in section 2.8. 
2.2 Virological methods 
2.2.1 Infection of avian and mammalian cells with IBV 
Cells were seeded to 70-80% confluency and infected with an appropriate volume of 
neat virus for the well size. The cells were incubated for 1 hr at 37 °C and 5% CO2. 
The virus inoculum was then removed and replaced with 1x BES media.  
2.2.2 Infection with IBDV 
DF1 cells were seeded to 70-80% confluency and infected with an appropriate 
volume of virus for the well size. The cells were incubated for 1 hr on a rocker at 
room temperature. The virus inoculum was then removed and replaced with DMEM 
growth media. 
2.2.3 Viral growth kinetics 
DF1 cells were seeded onto 12-well plates. The PI3K inhibitor LY294002 was 
diluted in DMEM growth media. Half of the wells were treated with 10 µM LY294002 
for 1 hr prior to, and for the duration of infection. Cells were infected with neat virus 
or mock infected and left to incubate at 37 °C for 1 hr. After 1 hr the inoculum was 
removed and 2 ml DMEM growth media was added to each well. At 1, 2, 6, 8, 12, 
18, 20 and 24 hours post infection (hpi) the supernatant was collected for titration by 
tissue culture infectious dose (TCID50). The cells were washed twice in PBSa and 
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lysed in 500 µl Qiagen RNeasy RLT buffer containing β-mecaptoethanol on ice for 
20 mins. The lysates were collected and 250 µl was stored at -80 °C for RNA  
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extraction. The other 250 µl was centrifuged at 12,000 rpm for 20 mins at 4 °C. The 
supernatant was collected and 1x Laemmli sample buffer (BIO-RAD) was added for 
subsequent protein analysis.  
2.2.4 Titration of IBV by TCID50 
DF1 cells were seeded onto 96-well plates. Supernatant from DF1 cells infected with 
IBV in the presence or absence of LY294002 were collected at 8, 12, 18, 20 and 24 
hpi (Section 2.2.3). The supernatants were serially diluted 10 fold to 10-8 in DMEM 
growth media. Cells were inoculated with 200 µl of each virus dilution in five 
replicates. Infected cells were left to incubate at 37 °C for 5 days. The number of 
wells containing cells exhibiting cytopathogenic effect (CPE) was counted by 
visualisation under a microscope and comparison to control wells. CPE was 
identified as a rounding of cells and disturbance of the monolayer. The TCID50 was 
calculated using the TCID50 calculator developed by Marco Binder, Dept. Infectious 
Diseases, Molecular Virology, Heidelberg University. TCID50 was calculated by the 
Spearman & Kӓrber algorithm (Heierholzer and Killington, 1996). 
2.2.5 Titration of IBV by plaque assay 
To measure the titre of new batches of IBV grown on CK cells, plaque assays were 
used as standard. CK cells were seeded into 12-well plates. Virus was serially 
diluted 10-fold in 1x BES medium and CK cells inoculated with 250 µl of virus. After 
1 hr the inoculum was removed and cells were overlaid with 2 ml 1x BES in 1% 
agar. Cells were incubated for 72 hrs at 37 °C, 5% CO2 then fixed by addition of 
10% formaldehyde in PBSa for 30 mins. Agar was removed and cells stained with 
0.1% crystal violet for 20 mins to visualise the plaques.  
2.2.6 Inactivation of IBV with BEI 
IBV was inactivated using Binary ethylenimine (BEI). A neat stock of virus was 
incubated in 0.1 M BEI for 48 hrs at 37 °C. After 48 hrs BEI was inactivated by the 
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addition of 1 M sodium thiosulfate. The inhibition of viral replication was confirmed 
by qPCR (Section 2.5.1) and the virus stored at -80 °C. 
2.3 Protein based methods  
2.3.1 Cell lysis for protein collection 
Cells were treated as per experimental design. At the time points indicated cells 
were washed twice with cold PBSa on ice. Cells were then lysed in 1x Cell Lysis 
Buffer (NEB) containing a phosphatase inhibitor. For 12-well plates cells were lysed 
in 350 µl cell lysis buffer. Immediately prior to lysis, 1x Protease Inhibitor Cocktail 
(NEB) was added to the lysis buffer. Cells were incubated on ice for 20 minutes and 
the lysate collected. Lysates were centrifuged at 13,000 rpm at 4 °C for 10 mins and 
the supernatants collected and stored at -20 °C. 
2.3.2 SDS-PAGE 
Cell lysates were denatured in 1x Laemmli Sample Buffer (BIO-RAD) containing β-
mecaptoethanol and heated to 100 °C for 10 minutes. Protein samples were loaded 
into a Mini-PROTEAN TGXTM Precast Gel (BIO-RAD) and electrophoresed in 
Tris/Glycine SDS running buffer (BIO-RAD) at 80 V for the first 10 mins then 110 V. 
2.3.3 Coomassie staining  
SDS-PAGE gels were incubated in Coomassie Brilliant Blue R-250 Staining Solution 
(BioRad) and de-stained using Coomassie Brilliant Blue R-250 Destaining Solution 
(BioRad) according to manufacturer’s protocol.  
2.3.4 Western blotting 
For western blotting, proteins separated by SDS-PAGE were transferred onto 
nitrocellulose membrane in Trans-Blot Turbo transfer buffer (BIO-RAD) using a 
Trans-Blot Turbo Transfer System (BIO-RAD). Membranes were submerged in 
Ponceau S solution (Sigma-Aldrich) for 5 mins to stain for total protein. This was to 
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ensure equal loading and check for bubbles on the membrane. The stain was 
removed by washing in sterile water. Membranes were then incubated for 1 hr or 
overnight in 2.5% Marvel/2.5% BSA and 0.1% Tween 20 in PBSa (PBST). The 
membrane was then washed once in PBST and incubated in primary antibody (see 
Table 2.1) for 1 hr or overnight.  Following this, the membrane was washed at least 
3 times in PBST and incubated with a fluorescent IRDye secondary antibody (LI-
COR) diluted 1:1000 in 1% BSA in PBST for 1 hr in the dark. The membrane was 
washed a further 3 times in PBST and the protein bands detected and quantified on 
an Odyssey CLx Imaging System (LI-COR).  
2.3.5 Fixing, labelling and staining for immunofluorescence 
Cells were seeded onto glass coverslips in 24-well plates and infected or treated as 
in previous sections. Cells were fixed either in the original 24-well plate, or 
coverslips were carefully moved into another 24-well plates for fixation during time 
courses. Plates were incubated on ice and cells were washed twice with cold PBSa 
then fixed in 250 μl 4% paraformaldehyde for 20 minutes on a rocker. Cells were 
then washed once in cold PBSa and stored at 4 °C for up to 72 hours after fixation, 
further processing was not done on ice.  
For staining of filamentous actin with Alexa Fluor Phalloidin 568 (ThermoFisher 
Scientific), cells were incubated in the dye diluted in PBSa at 1:500.  
For incubation in antibodies, cells were permeabilised with 0.1% Triton X-100 in 
PBSa for 10 minutes. After permeabilisation the cells were washed once with PBSa 
and blocked in 0.5% BSA in PBSa for 1 hr on a rocker. Cells were then incubated in 
primary antibody (Table 2.1) for 1 hour on a rocker. After incubation cells were 
washed five times in PBSa prior to incubation in fluorescent secondary antibodies at 
a concentration of 1:250 for 1 hr in the dark on a rocker. After 1 hr the cells were 
washed five times in PBSa. 
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After incubation in stain or antibodies, the nuclei of the cells were stained with DAPI 
(1:20,000) and mounted onto microscope slides with Vectashield Antifade Mounting 
Media (Vector Laboratories).  
Cells were imaged using a Leica TCS SP5 confocal Microscope 
2.3.6 Fixing for electron microscopy 
Electron Microscopy was performed by Jennifer Simpson, The Pirbright Institute. 
DF1 cells were seeded onto round plastic coverslips in 24-well plates to 90% 
confluency. Cells were mock infected or infected with IBV in the presence or 
absence of LY294002. At 24 hpi media was removed from cells and 1 ml fixative 
was added to the cell.   
EM fixative was made as follows, stored at -20 °C until use and thawed overnight at 
4 °C before use.  
Initially a 0.02 M buffer solution was using 50 ml Solution A and 32 ml Solution B 
(Table 2.6). The pH of the solution was checked and adjusted to 7.2 if needed.  
Table 2.6 Components of Solution A and B for fixative buffer preparation 
Solution A Solution B 
2.722g sodium dihydrogen 
orthophosphate in 100 ml distilled water 
0.8 g sodium hydroxide in 100 ml 
distilled water 
 
Subsequently, a 0.05 M buffer was made by diluting 1 part 0.2 M buffer in 3 parts 
distilled water and the pH re-confirmed as 7.2.  
The fixative was then made by adding 8 ml of 25% glutaraldehyde and 1.71 g 
sucrose to 92 ml of the 0.05 M buffer and mixed well.  
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2.4 Stimulation and Inhibition of PI3K/AKT pathway 
2.4.1 Cytotoxicity assays 
Cells were seeded onto 96-well plates to 90% confluency. Inhibitors (Section 2.4.2 & 
2.4.3) were diluted in growth media to various dilutions. Media was removed from 
the cells and replaced with 100 µl of the diluted inhibitors. Cells were incubated at 
37 °C for 24 hrs with the inhibitors. After 24 hrs the viability of the cells was 
assessed using the CellTiter-Glo Assay (Promega) according to manufacturer’s 
protocol. In short 50 µl of media was removed from the cells and discarded. Then 50 
µl CellTiter-Glo Reagent was added to the cells inducing lysis. Cells were mixed for 
2 mins on an orbital shaker and the plate incubated for a further 10 mins without 
shaking. The luminescence was measured using a GloMax Luminometer 
(Promega). 
2.4.2 Inhibition of PI3K by LY294002 
PI3K activity was inhibited by incubating the cells in a final concentration of 10 µM 
LY294002 for 1 hr prior to and for the duration of infection or treatment.  
2.4.3 Stimulation of PI3K/AKT by EGF 
The PI3K/AKT pathway was activated by incubating the cells in 5 ng/ml EGF for 15 
mins.  
2.5 RNA and DNA based methods 
2.5.1 Real-time qPCR for IBV detection 
TaqMan qPCR was performed using TaqMan® Fast Universal PCR 2x Master Mix 
(ThermoFisher Scientific). Primers and probes were designed by Helena Maier (The 
Pirbright Institute) (Maier et al., 2013b). Primers were used at 500 nM and hydrolysis 
probes at 125 mM final concentrations. 
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Copies of IBV genome were detected by amplifying the 5′-UTR of the viral genome. 
Table 2.7 Oligonucleotide sequences for 5′UTR primer/probe set  
Oligonucleotide Sequence 
IBV 5′ UTR (forward) 5′-GCTTTTGAGCCTAGCGTT-3′ 
IBV 5′ UTR (reverse) 5′-GCCATGTTGTCACTGTCTATTG-3′ 
IBV 5′ UTR probe 5′-(FAM)-CACCACCAGAACCTGTCACCTC-(TAMRA)-3′ 
 
Copies of viral mRNA were detected by amplifying the N-message mRNA produced 
during replication.  
Table 2.8 Oligonucleotide sequences for N-message primer/probe set 
Oligonucleotide Sequence 
N-message (forward) 5′-GCTTTTGAGCCTAGCGTT-3′ 
N-message (reverse 5′-TTGTCCCGCGTGTACCTCTC-3′ 
N-message probe 5′-(FAM)-ACAAAGCAGGACAAGCA-(TAMRA)-3′ 
 
The qPCR was run on a 7500 Fast Real Time System (Applied Biosystems) with the 
following cycle profile: 95 °C for 1 mins and then 40 cycles at 95 °C for 10 secs and 
60 °C for 30 sec.  
Copy number was calculated from a standard curve created from amplification of 
target sequences from plasmids containing the target sequences (Maier et al., 
2013b).  
2.5.1 Real-time PCR primer design 
Candidates for reference gene primers were identified using the GenScript Real-
time PCR (TaqMan) Primer Design tool (https://www.genscript.com/ssl-
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bin/app/primer). The candidate sets were then modified and final sets selected using 
the Primer Express Software (ThermoFisher Scientific). The primers were then 
ordered from Sigma at a stock concentration of 100 µM. Hydrolysis probes were 
ordered after the probes were tested for specificity and gDNA amplification by 
endpoint PCR. Primer and probe sets were designed in collaboration with Karen 
Staines (Lincoln University) and William Mwangi (The Pirbright Institute). Full primer 
sequences in Chapter 5, Table 5.3. 
2.5.2 Total RNA extraction from tissue 
Tissues were removed from Rhode Island Red chickens, aged between 8 days and 
3 weeks, and immediately stored in TRIzol (Thermofisher) at -80 °C. No more than 
100 mg of each tissue sample was placed into 500 µl TRIzol in a safelock tube 
containing a sterile metal bead. Tissues were disrupted in a bead beater until fully 
homogenised. Tissue debris was left to settle at room temperature for 5 mins before 
the addition of 100 µl chloroform. The tubes were shaken vigorously for 15 secs and 
left to settle again for 5 mins at room temperature. The samples were then 
centrifuged at 12,000 xg for 15 mins at 4 °C to separate RNA from DNA. The upper 
aqueous RNA phase was collected into a new tube and purified through an RNeasy 
Mini column (Qiagen) according to manufacturer’s protocol. The RNA was eluted in 
30 µl RNase-free water and quantified on a NanoDrop (Thermo Fisher Scientific).  
2.5.3 Total RNA extraction from cells 
Cells were lysed in RLT buffer containing β-mecaptoethanol on ice. RNA was 
extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s 
protocol. The RNA was eluted in 30 µl RNase-free water and quantified on a 
NanoDrop (ThermoFisher Scientific). 
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2.5.4 Reverse transcription  
RNA was reverse transcribed using SuperScript III Reverse Transcriptase 
(Invitrogen). RNA samples were diluted to 100 ng/µl. Between 500 ng and 1 µg of 
RNA was reverse transcribed using 50 ng of random primers according to the 
manufacturer’s protocol.   
2.5.5 End-point PCR 
End-point PCR reactions were performed using GoTaq DNA polymerase 
(Promega). Briefly 250 ng cDNA was added to, 1x Green GoTaq Reaction Buffer, 
0.5 µM forward and reverse primers, 1.25 U GoTaq DNA Polymerase and 0.2 mM 
dNTPs to a final volume of 50 µl in nuclease-free water. The PCR was run using the 
following cycling method: 95 °C for 5 mins, 30 cycles of 95 °C for 1 min, 54 °C for 1 
min, 72 °C for 1 min then 75 °C for 15 minutes. PCR product was stored at -20 °C. 
2.5.6 Agarose gel electrophoresis 
The PCR products produced in 2.5.5 were run on a 1% TBE agarose gel  containing 
ethidium bromide at 50 V. Gels were then imaged using a Gel Doc EZ Gel 
Documentation System (BioRad). 
2.5.7 Real-time quantitative PCR with SYBRgreen 
The SYBRgreen qPCR was performed using the Power SYBR Green Master Mix 
(ThermoFisher Scientific) and a final concentration of 0.3 µM each primer. 
Amplification and detection was performed with a 7500 Fast Real Time System 
(Applied Biosystems) using the following cycle profile: 50 °C for 20 sec, 95 °C for 10 
min and then 40 cycles of 95 °C for 15 sec, 60 °C for 1 min. On completion of 
cycling, a dissociation stage was run.  
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2.5.8 Real-time quantitative PCR with TaqMan hydrolysis probe 
Quantitative PCR was performed using 1x TaqMan Universal PCR Master Mix and a 
final concentration of 0.5 µM each primer and 50 nM hydrolysis probe in a 20 µl 
reaction. Amplification and detection of the specific products was performed with the 
7500 Fast Real Time System (Applied Biosystems) with the following cycle profile: 
50 °C for 5 min, 95 °C for 2 min and then 40 cycles of 95 °C for 3 sec and 60 °C for 
30 sec. A total of 500 ng of reverse transcribed RNA was used for each reaction. 
2.5.9 Reference gene stability analysis by geNorm 
The Cq values of each candidate reference gene across the subset of samples were 
calculated using the 7500 Fast Real-Time PCR Software version 2.3. (Life 
Technologies). Raw Cq values were then exported as .csv files and imported into the 
qbase+ real-time qPCR software version 3.0 (Biogazelle). The software employs the 
geNorm algorithm (Vandesompele et al., 2002) to calculate the geNorm M value 
representing the stability of each reference genes and the geNorm V values which 
suggest the optimal reference gene number. 
2.5.10 Real-time quantitative PCR data analysis 
The quantification cycle (Cq) values for each sample were calculated on the 7500 
Fast Real-Time PCR Software version 2.3 (Life Technologies). Raw Cq values were 
then exported as .csv files and imported into Qbase+ Real-time qPCR Software 
version 3.0 (Biogazelle) where Cq values were normalised to those of reference 
genes and the relative expression of each gene was calculated in each sample. The 
software also allowed quality control where by the consistency of technical 
replicates could be confirmed.  
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2.6 Analysis of Macropinocytosis 
2.6.1 Stimulation of macropinocytosis 
DF1 or Vero cells were seeded onto glass coverslips in 24-well plates to 80% 
confluency. Cells were treated with 400 nM Porbol-12-myristate-13-acetate (PMA) 
or DMSO control for 1 hr.  
2.6.2 Inhibition of macropinocytosis 
DF1 or Vero cells were seeded onto glass coverslips in 24-well plates to 80% 
confluency. Cells were inhibited with 1 mM Amiloride or DMSO control for 1 hr prior 
to infection.  
2.6.2 Fluorescent Nanoparticle Uptake 
DF1 or Vero cells were stimulated with PMA, mock infected or infected with IBV on 
glass coverslips in a 24-well plate in triplicate. The nanoparticles used were blue-
green 1.0 µm fluorescent (430/465) Fluospheres Polystyrene Microspheres for 
tracer studies (Life Technologies). A concentration of 100 nanoparticles (np) per cell 
was calculated and added to each well for 20 mins prior to and for the duration of 
the infection/treatment. At the indicated time points the cells were washed 3x in 
PBSa and fixed in 4% paraformaldehyde in PBSa for 20 minutes on ice. Coverslips 
were then stained with DAPI (4',6-diamino-2-phenylindole) at 1:10,000 in water and 
mounted onto glass slides. The number of cells containing at least one nanoparticle 
were counted in three random fields of view on each replicate. If more than 25 cells 
were visible in a given field of view only the first 25 cells were counted. Cells 
containing the nanoparticles were identified by scanning through the z-axis of the 
cell to identify particles present within the cell rather than on the surface or below. 
Cells were imaged on Leica TCS SP5 Confocal Microscope. 
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2.7 Analysis of Apoptosis 
2.7.1 Stimulation of apoptosis 
Cells were seeded onto 96-well plates to 80% confluency. Apoptosis was stimulated 
by treatment with 10 µM Staurosporine from point of infection at 0hpi. 
2.7.2 Caspase 3/7 Cleavage Assay 
Cells were seeded into 96-well plates to 80% confluency. Cells were then either 
stimulated with staurosporine, mock infected or infected with IBV in the presence or 
absence of LY294002 (see 2.4.2). Cells were incubated in the inoculum for 1 hr at 
37 °C and 5% CO2. After 1 hr the inoculum was removed and replaced with 100 µl 
growth media per well (also containing LY294002). Measurement of caspase 3/7 
cleavage was performed using the Caspase-Glo 3/7 Assay (Promega). At various 
time points post infection 50 µl of the media was removed and replaced with 50 µl of 
the luminescent caspase substrate. The cells were shaken for 2 mins to lyse the 
cells and then incubated for 1 hr at room temperature in the dark. After 1 hr, 80 µl of 
the substrate was removed and placed into a white opaque 96–well plate for reading 
on a GloMax Luminometer (Promega). 
2.7.3 Annexin-V-FITC FACS Assay 
Cells were seeded into 12-well plates to 80% confluency. Cells were then either 
stimulated with staurosporine, mock infected or infected with IBV. Cells were then 
detached from the plates with Accutase Cell Detachment Solution in PBS. The FITC 
Annexin V Apoptosis Detection Kit II (BD Biosciences) was used to determine the 
number of cells undergoing apoptosis by flow cytometry. The assay was run 
according to the manufacturers protocol. Detached cells were washed in cold PBSa 
and resuspended in 1 ml 1x Binding Buffer. 100 μl of the suspension was 
transferred to a 5 ml FACS tube and 5 μl FITC Annexin V was added. The cells 
were gently vortexed and incubated for 10 mins at room temperature in the dark. 5 
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μl of PI was then added and incubated for a further 5 mins in the dark. 400 μl 1x 
Binding Buffer was then added to the suspension and fluorescence was immediately 
analysed on a MACS QUANT flow cytometer.   
The flow cytometry analysis is illustrated in Appendix 1-3 and was performed as 
follows. A population of DF1 cells was selected for by gating, removing cellular 
debris. Single cells were subsequently selected for on an SSC area vs height plot. 
The population of single cells was then plotted on an Annexin V-FITC vs PI plot and 
quadrant gates added.  
 
2.8 Cloning of IBV structural proteins 
2.8.1 Primer design 
Primers were designed to amplify the region of the IBV genome encoding either the 
envelope (E) or membrane (M) protein.  
Table 2.9 Oligonucleotide sequences for IBV_E and IBV_M expression plasmids 
Oligonucleotide Sequence 
Beau-R_ E_Fwd 5'-TATAGCGGCCGCATGAATTTATTGAATAAGTCGC-3' 
Beau-R_E_Rev 5'-ATATAAGCTTTCAAGAGTACAATTTGTCTCGTTGG-3' 
Beau-R_M_Fwd 5'- TATAGCGGCCGCATGCCCAACGAGACAAATTG-3' 
Beau-R_M_Rev 5'-ATATAAGCTTCTAAGCGTAATCTGGAACATCGTATGGGTATGTGTAAAGACTACTTCC-3' 
Restriction sites for NotI and Hind III were included in both designs (yellow and blue 
respectively). The M primers were designed including an HA tag on the reverse primer as no 
anti-M antibody was available (pink). 
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2.8.2 Amplification of insert and PCR purification 
An endpoint PCR was run to amplify the Beau-R_E or Beau-R_M inserts. The 
amplification was performed using Platinum Taq DNA Polymerase High Fidelity 
(ThermoFisher Scientific). One unit (U) of Taq was added to a final concentration of 
1x High Fidelity PCR Buffer, 2.0 mM MgSO4, 0.2 mM dNTPs (each), 0.2 µM each 
primer and 500 ng Beau-R virus stock cDNA in a 50 µl reaction. The following cycle 
profile was used: 94 °C for 30 sec then 35 cycles of 94 °C for 15 sec, 65 °C for 30 
sec and 68 °C for 1 min. PCR products were then visualised by running on a 1% 
TBE agarose gel containing ethidium bromide. The products were then extracted 
from the gel using a Qiaquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s protocol. DNA was eluted in 30 µl elution buffer. 
2.8.3 Restriction Digests 
Both PCR products were digested alongside the pcDNA 3.1 (-) vector using Not1-
HIFI (High Fidelity) and HindIII in buffer 2.1 (NEB). Fifteen µl of the purified PCR 
product was digested with 2.5 µl of the buffer, NotI, HindIII and nuclease-free water. 
3 µg of the vector was digested with 2 µl of buffer, 2 µl Not1, 2 µl HindIII and 1 µl 
alkaline phosphatase in 9 µl nuclease-free water. Both samples were digested for 2 
hrs at 37 °C and stored at -20 °C. 
2.8.4 Ligation 
The Beau-R_E and Beau-R_M inserts were inserted into the pcDNA 3.1 (-) vector 
using T4 Ligase (NEB) according to the manufacture’s protocol. Ligation was 
performed overnight at 15 °C.  
2.8.5 Transformation into competent cells 
The samples were transformed in NEB 5-alpha Competent E. coli (High Efficiency) 
cells (NEB). Three µl of the ligation mix made in 2.8.4 was added to 50 µl competent 
cells and incubated on ice for 20 mins. After 20 mins the cells were heat-shocked at 
 Page | 79 
 
79 Chapter 2 – Materials and Methods 
42 °C for 45 secs before being returned to ice for 2 mins. 250 µl SOC media was 
added and the transformation mix incubated at 37 °C for 1 hr in a shaking incubator. 
100 µl of the mix was then plated onto ampicillin plate and incubated overnight at 37 
°C.  
2.8.6 Plasmid Miniprep 
From the colonies grown on the ampicillin plates in 2.8.5, 6 colonies were picked 
and grown in LB containing ampicillin resistant bacteria overnight at 37 °C in a 
shaking incubator. A glycerol stock was made by mixing 600 µl overnight culture 
with 400 µl glycerol and stored at -80 °C. Plasmids from the remaining culture was 
purified using a Plasmid Miniprep Kit (Qiagen) according to manufacturer’s protocol. 
The plasmids were then digested according to the protocol in 2.8.3 and visualised 
on a 1% TBE gel to ensure that the insert was present. Plasmids were also 
sequenced by sanger sequencing.   
2.8.7 Plasmid DNA Maxiprep 
From the glycerol stocks prepared in 2.8.6 a new 100 ml culture of plasmid was 
grown and the plasmid DNA purified using a Plasmid DNA Maxiprep Kit (Qiagen) 
according to the manufacturer’s instructions.  
2.8.8 Transfection of plasmids into DF1 cells 
DF1 cells were seeded onto 12-well plates or on glass coverslips in 24-well plates 
for immunofluorescence to 80% confluency. Cells were transfected with expression 
plasmids using Lipofectamine 2000 (ThermoFisher Scientific) according to the 
manufacturer’s protocol. A ratio of 2 µl:1 µg of lipofectamine 2000 to plasmid was 
used. Transfection was performed in Optimem media for 24 hrs.  
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2.9 Statistical Analysis 
All graphs were created and statistical analysis performed using GraphPad Prism 7 
(GraphPad Software, Inc.). For each data set the type of statistical analysis used is 
noted in the figure legend.   
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3.1 Introduction 
All viruses, as intracellular parasites, require control over cellular machinery to 
replicate within the cell. Signalling pathways of host cells are often modulated during 
viral infection. One of the most commonly used pathways is PI3K/AKT, which 
controls processes such as translation, protein synthesis, actin re-arrangement, 
glycogen synthesis, cell cycle progression and cell death. The earliest point at which 
the host cellular pathways are modulated by a virus is during initial attachment and 
entry into the cell. However, pathways are also modulated to induce pre-mRNA 
splicing (Hillebrand et al. (2014), cell survival (Bagchi et al. (2010) and protein 
synthesis (Johnson et al. (2001). Molecular interactions between cellular signalling 
pathways and IBV are examined in this chapter. The effect of IBV infection on the 
activation state of AKT, in the context of PI3K/AKT signalling, has been investigated. 
PI3K specific inhibitors were utilised to understand the importance of signalling 
pathways in viral replication. The structural proteins of other coronaviruses have 
been implicated in the activation of cellular signalling pathways (Tsoi et al., 2014). 
We therefore investigated the effect of over expression of the IBV structural proteins 
on PI3K/AKT modulation.  
3.2 Cellular tropism of IBV strains M41 and Beau-R 
The phenotypes and cellular tropism of different coronaviruses are often determined 
by variations in the spike protein, which is involved in receptor binding and 
membrane fusion with the host cell. Two laboratory strains of IBV were used in this 
study. The first is the pathogenic M41 strain that has been adapted to grow in chick 
kidney cells (CK cells) (Darbyshire et al., 1979). The second is the apathogenic 
molecular clone of Beaudette CK (Beau-R) (Casais et al., 2001). Beau-R, in 
comparison to M41, has an extended cellular tropism.  
In order to confirm these reports, the tropism of both viruses was investigated in a 
variety of cell types by immunofluorescence (Figure 3.1).  
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The susceptibility of the mammalian kidney cell line, Vero, was compared to that of 
various avian cell types. The avian dendritic fibroblast line of DF1 cells, the HD11 
macrophage cell line and primary chick kidney (CK) cells were also tested. All cells 
were infected with M41 for 24 hrs. The cells were fixed and labelled with antibodies 
against the golgi apparatus (anti-golgi), the endoplasmic reticulum (anti-ER) and 
anti-dsRNA to identify viral infection. Nuclei were stained with DAPI. Some dsRNA 
labelling was observed in the mammalian Vero cell line. However, the extent of 
labelling was lower than that in the avian CK cells, in which the virus is regularly 
grown and titrated. Infection of the avian DF1 cell line was also very low, with only 
one or two cells showing dsRNA labelling per field of view. No dsRNA was observed 
in HD11 cells infected with M41. The same cell lines were also infected with Beau-
R. In contrast to M41 infected cells, high levels of dsRNA labelling was observed in 
the Vero, CK and DF1 cells infected with Beau-R. The Beau-R infected HD11 cells 
exhibited a very low level of dsRNA labelling with only one or two cells infected per 
field of view. The ability of the virus to infect both mammalian and avian cells was 
essential for this project to allow the comparison of signalling modulation during 
infection of different cell types. Therefore, for the purpose of this study, Beau-R was 
used as a model for IBV infection in mammalian and avian cells, unless otherwise 
stated.  
3.3 AKT activation during IBV infection 
3.3.1 IBV infection induces AKT activation in mammalian cells in a 
PI3K-dependent manner 
The immunofluorescence study shown in Figure 3.1 demonstrated the ability of the 
IBV strain Beau-R to infect and replicate within mammalian Vero cells.  The 
PI3K/AKT signalling pathway is well characterised in mammalian cells and has been 
shown to be activated by receptor tyrosine kinases (RTK) at the cellular membrane. 
One known activator of RTKs is epidermal growth factor (EGF). To assess AKT 
 Page | 87 
 
87 Chapter 3 – PI3K/AKT activation during IBV infection 
activation by EGF, Vero cells were mock treated with DMSO or EGF for 15 minutes 
(Figure 3.2). The cells were lysed, proteins separated by SDS-PAGE and 
transferred onto nitrocellulose membranes. Western blots were performed using an 
AKT antibody specific to the S473 phosphorylated form of the protein (anti-pAKT 
S473) and anti-β-actin (Figure 3.2A).   
Densitometric analysis of the western blot demonstrated elevated levels of pAKT 
S473 in the EGF stimulated cells relative to control, and normalised to levels of β-
actin (Figure 3.2B). The AKT signalling pathway is involved at various points during 
viral replication. To determine whether IBV infection activated AKT, and to identify at 
which time points this occurred, Vero cells were infected with IBV and lysed at 2, 6 
12 and 24 hpi. Western blots were ran as previously described and probed with anti-
pAKT S473 and anti-β-actin (Figure 3.3A). Densitometric analysis showed that 
pAKT S473 levels began to increase at 6 hpi with large increases in activation seen 
at 12 and 24 hpi (Figure 3.3B).  
Activation of AKT can occur in a PI3K-dependent or independent manner. To 
determine whether IBV-induced activation of mammalian AKT was PI3K dependent, 
PI3K was inhibited using a specific inhibitor, LY294002.  
Initially, the cytotoxicity of LY294002 in Vero cells was assessed using the CellTitre 
–Glo assay (Promega) that measures the quantity of metabolically active cells 
(Figure 3.4A). The viability of the cells was not significantly affected by the addition 
of LY294002 at final concentrations of either 10 or 20 µM. However, at 50 µM 
cellular activity decreased significantly (p<0.02). The efficacy of LY294002 at 10 µM 
was assessed by western blot (Figures 3.4B & 3.4C). Vero cells were mock 
stimulated with DMSO or stimulated with EGF in the presence or absence of 
LY294002. After 15 minutes the cells were lysed and separated by SDS-PAGE.  
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Proteins were then subjected to western blotting and probed with anti-pAKT S473 
and anti-β-actin (Figure 3.4B). Analysis of the western blots showed an increase in 
pAKT S473 in cells stimulated with EGF. However, this activation was inhibited by 
LY294002 at 10 µM (Figure 3.4C).    
Vero cells were subsequently infected with IBV in the presence or absence of the 
LY294002. At 12 and 24 hpi the cells were lysed, proteins separated by SDS-PAGE 
and transferred onto membrane for western blotting. The membranes were probed 
with anti-pAKT and anti-β-actin (Figure 3.5A). Whilst IBV infection induced activation 
of AKT at 24 hpi, analysis of the blots showed that treatment of cells with LY294002 
prevented this, indicating that IBV induced activation of AKT occurs in a PI3K-
dependent manner in mammalian cells (Figure 3.5B).  
3.3.2 IBV infection of avian cells induces AKT activation in a 
biphasic manner  
Recombinant mammalian EGF was previously shown to activate AKT in mammalian 
cells (Section 3.3.1). Its effect on avian cells was subsequently investigated. DF1 
cells were treated with either 5 ng/μl or 10 ng/μl of EGF and lysed at different time 
points. Western blots were prepared and probed with anti-pAKT S473 and anti-β-
actin (Figure 3.6). Treatment of DF1 cells with EGF did not induce AKT activation at 
any time point or concentration tested. Stimulation of PI3K/AKT signalling with 
lipopolysaccharides (LPS) was also tested (data not shown). However, LPS 
stimulation also did not induce AKT activation. Therefore, infectious bursal disease 
virus (IBDV) was used as a positive control as it is known to activate AKT (Wei et 
al., 2011). DF1 cells were mock infected or infected with IBDV at a MOI of 10. Cells 
were lysed at 8, 12, 18 and 24 hpi and proteins separated by SDS-PAGE. Western 
blots were incubated in anti-pAKT S473 or anti-β-actin (Figure 3.7). The western 
blot confirms the findings of Wei et al. (2011).  
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IBDV infection of DF1 cells induces phosphorylation of AKT at S473 over time with a 
peak at 8 hpi. In the absence of another positive control, IBDV infection was used. 
The effect of LY294002 on AKT activation in avian cells was consequently 
investigated using IBDV as a positive control. Initially the cytotoxicity of LY294002 in 
DF1 cells was established using a cell titre assay (Figure 3.8A). The viability of DF1 
cells was not significantly affected by addition of LY294002 at 10 μM, however at 
100 μM the cellular activity decreases significantly (p<0.0001). DF1 cells were more 
sensitive to the effects of LY294002 than Vero cells, with a decrease of 7.4 RLU in 
Vero cells and 11.4 RLU in DF1 cells from 0 μM to 100 μM. Subsequently DF1 cells 
were mock infected or infected with IBDV in the presence or absence of 10 µM 
LY294002. Cells were lysed at 8 hpi and western blots probed with anti-pAKT S473 
and anti-β-actin (Figure 3.8B). Analysis of the western blot showed pAKT S473 
activation in IBDV infected cells which was inhibited by the presence of LY294002 
(Figure 3.8C).  
The effect of LY294002 on IBV-induced activation of AKT was investigated. Avian 
DF1 cells were infected with IBV in the presence or absence of LY294002 and at 2, 
8, 12, 16 and 24 hpi, the cells lysed, proteins separated by SDS-PAGE and western 
blots incubated with anti-pAKT S473 and anti-β-actin (Figure 3.9A). Densitometric 
analysis of the western blot showed that, in the absence of LY294002, IBV induced 
a biphasic activation of AKT that increased at 2 hpi, was supressed by 8 hpi and 
then increased again from 16 to 24 hpi (Figure 3.9B).  
In all replicates in the presence of LY294002, AKT activation was suppressed at 16 
and 24 hpi. However, there was variation in pAKT S473 levels during PI3K inhibition 
at earlier time points. This suggests that that the modulation of AKT at these early 
time points may be dependent on several factors which result in large variation 
between samples. 
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Complete activation of AKT in mammals requires phosphorylation at two sites, S473 
and T308. Therefore, it could be hypothesised that variations in avian pAKT T308 
would be consistent with those of pAKT S473 during IBV infection.  
To establish this, lysates from mock or IBV infected DF1 cells in the presence or 
absence of LY294002 were subjected to western blot. Blots were probed with anti-
pAKT T308 and anti-β-actin (Figure 3.10A). Analysis of the western blots show a 
similar pattern of T308 phosphorylation as S473 (Figure 3.10B). A biphasic 
phosphorylation of AKT at T308 was seen and activation at 24 hpi was found to be 
dependent on PI3K activity.   
3.3.3 Initial phase of AKT phosphorylation is dependent on viral 
entry  
Several viruses have been found to modulate the PI3K/AKT signalling pathway to 
aid cell entry. Interestingly, HIV has been found to activate signalling pathways as 
early as a minute post infection (Wojcechowskyj et al., 2013). AKT activation occurs 
early during infection in avian cells (Section 3.3.2). In order to assess whether the 
activation of AKT was a result of receptor biding and viral entry, an inactivated form 
of IBV was prepared (methods section 2.2.6). The viral RNA of Beau-R was 
inactivated with 0.1M binaryethylemine (BEI) without affecting viral proteins, allowing 
the virion to bind to cellular receptors and enter the cell but not replicate.  
In order to ensure that replication was inhibited, qPCR was used to quantify copies 
of viral genome alongside wild-type (wt-IBV) infected cells (Figure 3.11A). A four log 
increase in genome copy number in wt-IBV infected cells was seen at 24 hpi. 
However, no significant increase in viral genome copy number was observed with 
the inactivated virus.  
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To ensure entry of the virus into the cells, DF1 cells were mock infected or infected 
with the inactivated IBV. At 30 mins post infection, cells were fixed and labelled with 
anti-IBV S2, to indicate virions, and anti-tubulin (Figure 3.11B). Nuclei were stained 
with DAPI. IBV S2 labelling is localised within the cytoplasm as indicated by tubulin, 
suggesting that the virus was capable of binding and entry. Taken together, these 
data demonstrate that the inactivated virus binds and enters the cell, however is not 
able to replicate.   
Having successfully created an inactivated form of IBV, DF1 cells were infected with 
the wild-type or inactivated virus and lysed at 30 mins, 1 and 24 hpi. The proteins 
were separated by SDS-PAGE, transferred to a membrane and probed with anti-
pAKT S473 and anti-β-actin (Figure 3.12A). Levels of pAKT S473 were normalised 
to levels of β-actin. Densitometry results for both wt-IBV and inactivated IBV 
samples were normalised to mock. Analysis of the western blots demonstrated an 
increase in the activation of AKT as early as 30 mins post infection  in cells infected 
with the wild type as well as the inactivated IBV (Figure 3.12B). This suggests that 
binding of viral proteins to cellular receptors, fusion of viral membrane or presence 
of viral genome in the cell is sufficient to activate AKT.  
3.4 Replication of IBV requires an active PI3K/AKT signalling 
pathway 
The role of the PI3K/AKT signalling pathway in the replication of other viruses has 
been well documented. Many viruses require an active PI3K/AKT pathway to 
replicate efficiently within a cell, and activation of the pathway is often induced by 
the virus. It is therefore possible that IBV induces AKT activation to promote viral 
replication. If correct, inhibition of the pathway may affect replication of the virus. 
This was investigated and the effect of PI3K inhibition was determined at various 
points during the viral replication cycle. 
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3.4.1 Viral genomic and sub-genomic RNA 
DF1 cells were infected with IBV in the presence or absence of the PI3K inhibitor 
LY294002, and RNA extracted from the cells at 1, 2, 6, 12 and 24 hpi. The 
replication of viral genome was measured by amplification of the 5' untranslated 
region (5' UTR) of the genome by qPCR and genome copy number was calculated 
by interpolating of Cq values from a standard curve (Figure 3.13A). Production of 
viral genome is significantly delayed during PI3K inhibition from 6 hpi to 24 hpi 
(p<0.01) (Figure 3.13B). The levels of viral mRNA synthesis was measured by 
amplification of mRNA encoding the nucleocapsid protein (N-message). Copy 
number was again calculated by interpolating the data on a standard curve (Figure 
3.14A). In contrast to levels of viral gRNA, viral mRNA transcription was not 
significantly affected by inhibition of the AKT pathway with similar levels of 
transcription in both sample sets (Figure 3.14B).  
3.4.2 Translation of viral proteins 
The effect of PI3K inhibition on levels of intracellular viral protein was also 
investigated. DF1 cells were infected with IBV in the presence or absence of 
LY294002 and lysed at 2, 8, 12 and 24 hpi for western blot analysis. The 
membranes were probed with anti-S2 and anti-β-actin as a loading control (Figure 
3.15A). Levels of anti-S2 were normalised to β-actin. Densitometric analysis of the 
western blot suggests a decrease in viral protein production by 24 hours post 
infection during inhibition of PI3K (Figure 3.15B).   
3.4.3 Infectious virus particle release 
The delay in viral genome replication and protein synthesis was examined in the 
context of production and release of new infectious virions. The supernatant from 
infected DF1 cells was collected and the released virus titrated by TCID50 in DF1 
cells (Figure 3.16). 
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Inhibition of PI3K led to a significant decrease in release of virus from 20 hpi in the 
presence of LY294002 (p<0.001). By 24 hpi, there was a 4 log difference in titre. 
This correlated with levels of viral protein that were also lower during PI3K inhibition 
by 24 hpi (Figure 3.14).   
3.4.4 Possible replication sites and membrane structures 
One feature of all positive-strand RNA viruses is rearrangement of cellular 
membranes during infection. These membrane rearrangements occur to facilitate 
viral RNA synthesis through the formation of replication-transcription complexes. 
The type of membrane structures formed differs between families of virus. 
Membrane rearrangements observed vary from single- to double-membrane 
vesicles, to convoluted membranes and spherules. The origin of the membranes 
also changes between viruses, with membrane rearrangements found to be derived 
from intracellular vesicles, ER, Golgi, mitochondrial and plasma membrane.   
Recently, studies into membrane rearrangements during IBV infection have 
identified double-membrane vesicles, but also novel structures that have not been 
seen in coronaviruses before (Maier et al., 2013b). Maier et al. (2013b) observed 
spherules connected to regions of ER that had become zippered together. The 
spherules contain a channel connecting the interior of the spherule to the cytoplasm. 
The channel has a large enough diameter to allow the exchange of nucleotides and 
RNA products (Kopek et al., 2007). It is therefore possible that these spherules are 
the site of viral RNA synthesis.  
Inhibition of PI3K by LY294002 results in a decrease in viral replication and in 
particular a suppression of viral RNA synthesis. It was therefore hypothesised that 
PI3K/AKT signalling may be involved in the formation of viral RNA replication 
complexes. DF1 cells were therefore infected with IBV in the presence or absence 
of LY294002 and at 24 hpi were chemically fixed for transmission electron 
microscopy (TEM) analysis (Figure 3.17). The TEM analysis was kindly performed 
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by Jennifer Simpson (The Pirbright Institute). IBV infected DF1 cells exhibited 
double-membrane vesicles as well as spherules attached to zippered-ER. These 
membrane re-arrangements were not observed in the mock infected cells. Inhibition 
of PI3K with LY294002 induced no visible change in membrane re-arrangements in 
IBV infected cells, and the cells exhibited both double membrane vesicles and 
spherules attached to zippered-ER. Together this data suggests that the delay in 
viral RNA synthesis, observed in the presence of LY294002, is not a result of 
modifications to membrane re-arrangements.  
 Page | 109 
 
109 Chapter 3 – PI3K/AKT activation during IBV infection 
  
 Page | 110 
 
110 Chapter 3 – PI3K/AKT activation during IBV infection 
3.5 Role of IBV structural proteins in PI3K/AKT modulation  
The viral proteins responsible for modulating PI3K/AKT pathway in other nidoviruses 
have been identified. For example, the M protein of SARS-CoV is known to interact 
with the PI3K/AKT signalling pathway (Chan et al., 2007). In order to identify which 
viral proteins are involved in the induction of the biphasic activation of AKT during 
IBV infection, several expression plasmids were produced (Methods section 2.8) 
Plasmids expressing the IBV membrane (M) and envelope (E) proteins were 
transfected into DF1 cells. After 24 hours cells were fixed, permeabilised and 
labelled with anti-E or anti-FLAG (for overexpression of M protein) (green), anti-
tubulin (red) and DAPI (Figure 3.18A). Transfection of the expression plasmids 
resulted in overexpression of the respective viral proteins in DF1 cells. DF1 cells 
were then transfected and lysed after 24 hours for western blot analysis. The blots 
were probed with anti-pAKT S473 and anti-β-actin (Figure 3.18B). Analysis of the 
western blot suggested that an overexpression of IBV M but not E protein may result 
in activation of AKT, albeit marginal (Figure 3.18C).  
The effect of overexpression on the spike (S) and nucleocapsid (N) proteins was 
also investigated. Expression of N and S were confirmed by immunofluorescence. 
DF1 cells were transfected, fixed, permeabilised and labelled with anit-S2, anti-N 
and anti-tubulin (Figure 3.19A). Nuclei were stained with DAPI. A duplicate set of 
transfected cells were lysed, proteins separated by SDS-PAGE and transferred onto 
a membrane. The membranes were then probed with anti-pAKT S473 and anti-β-
actin (Figure 3.19B). Analysis of the western blot identified little change in pAKT 
levels during overexpression of IBV S. Overexpression of the N protein resulted in 
decreased levels of pAKT S473 in 4 out of 5 replicates however this was not 
conclusive due inconsistencies between replicates (Figure 3.19C).  
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3.6 Discussion 
The results presented in this chapter detail studies of the interaction between IBV 
and the PI3K/AKT signalling pathway. Initially the cellular tropism of the pathogenic 
strain of IBV (M41), and the apathogenic recombinant Beaudette strain (Beau-R) 
were assessed. IBV is the aetiological cause of the respiratory disease Infectious 
Bronchitis and therefore initially infects cells of the respiratory tract of chickens. 
However, pathogenic strains of IBV have also been found to infect other organs 
such as the kidney, where infection is known to cause nephropathology (Winterfield 
and Albassam, 1984, Abdel-Moneim et al., 2009). The receptors for IBV in its native 
host cells remain unknown, however it is thought that aminopeptidase N (APN) and 
sialic acid may be important for primary attachment (Miguel et al., 2002, Winter et 
al., 2006). Among other factors, the furin content of the cell is thought to have an 
effect on the ability of the virus to infect and replicate within a cell (Yamada et al., 
2009). Our immunofluorescence studies in Section 3.2 confirm the findings of 
others, that the Beau-R strain of IBV has a wider cellular tropism than the 
pathogenic M41 strain. Both strains of IBV were able to replicate in primary CK cells 
as expected. Beau-R, but not M41, was also able to replicate in the avian DF1 and 
mammalian Vero cell lines.  
The low levels of dsRNA labelling seen in some cell lines do not necessarily 
correspond with low levels of infection. It was previously thought that dsRNA was a 
replicative intermediate that occurs as a result of viral RNA synthesis. However, 
recent immunofluorescence studies in our laboratory have demonstrated that 
dsRNA does not co-localise with the RNA-dependent RNA polymerase (RdRP) 
suggesting that it occurs independently of RNA synthesis sites (Maier et al. 2016). 
Whilst the function and origin of dsRNA is unknown during IBV infection, it remains a 
reliable marker for viral infection in the absence of adequate IBV specific antibodies.  
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The activation of AKT was assessed with antibodies specific to the active form of the 
kinase, when phosphorylated at S473. Levels of phosphorylated AKT were 
normalised to cellular levels of β-actin, a protein commonly used for western blot 
analysis (Soares et al., 2009). Several studies have previously normalised AKT 
phosphorylation to the amount of total AKT being expressed in the cell (Sharma et 
al., 2010, Liu et al., 2012). This method of normalisation was attempted, however 
the antibodies used did not produce consistent results when tested on the avian 
samples. Therefore, there is the potential that any change in AKT phosphorylation 
seen may be a result of the differential expression of the AKT protein. However, 
other studies have demonstrated that levels of AKT protein expression remain 
constant throughout viral infection, and it is widely accepted that control of AKT 
signalling occurs via phosphorylation of AKT.  
The mammalian PI3K/AKT signalling pathway is modulated upstream by receptor 
tyrosine kinase receptors which can be activated by cytokines and growth factors 
such as epidermal growth factor (EGF). The ability of EGF stimulation to activate 
AKT was demonstrated by western blot (Figure 3.2). Subsequently the effect of IBV 
infection on the mammalian AKT signalling pathway was investigated. An increase 
in pAKT S473 was seen from 6 to 24 hpi. The most widely studied activation 
pathway of AKT involves PI3K. Activation of PI3K induces the accumulation of PIP3 
which prompts recruitment of AKT to the cellular membrane. Downstream processes 
of this pathway include mTOR signalling, apoptosis, protein synthesis, translation 
and cell growth. PI3K-independent activation of AKT has also been documented in 
mammalian cells. Whilst activation of AKT can occur independently of PI3K, many 
mammalian viruses have been found to modulate AKT through PI3K (Wang et al., 
2014c, Diehl and Schaal, 2013). Alongside others, the human coronavirus MERS-
CoV is known to modulate mTOR signalling via PI3K/AKT (Kindrachuk et al., 2015). 
The effect of IBV infection on the PI3K/AKT signalling pathway was therefore 
examined using a specific PI3K inhibitor, LY294002. In Vero cells, treatment with 
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LY294002 supressed EGF induced AKT activation (Figure 3.4). They were then 
infected with IBV at 12 and 24 hpi and the phosphorylation of AKT was also 
supressed by the inhibitor at 24 hpi (Figure 3.5). It can therefore be concluded that 
in mammalian cells IBV induces activation of AKT late during infection and that the 
activation is dependent on active PI3K.  
Studies of avian viruses are often performed in mammalian cells due to an 
abundance of reagents and a lack thereof in the avian field. Whilst not the perfect 
model for avian viral replication, many insights can be drawn from these studies. 
The mammalian AKT signalling pathway has been well characterised however few 
studies have investigated its avian counterpart. In this chapter the effect of IBV 
replication on the mammalian PI3K/AKT signalling pathway was compared to that of 
the avian pathway. Understanding how viruses interact with different cell types may 
give us insights into the basic cellular biology of the different cells. The effect of IBV 
infection on the avian AKT signalling pathway was investigated by western blot 
(Section 3.3.2). EGF was evaluated for use as a positive control in avian cells. 
However, it did not induce AKT activation at any concentration or time tested (Figure 
3.6). The EGF used was a recombinant mammalian protein, suggesting that EGF or 
the EGF receptor (EGFR) in avian cells may be different to that of mammalian cells. 
Another known stimulator of PI3K/AKT signalling, LPS was also tested (data not 
shown), however this was also unable to stimulate AKT phosphorylation in avian 
cells. Therefore IBDV was used as a known activator of PI3K/AKT signalling (Wei et 
al., 2011) and the activation confirmed by western blot of infected DF1 cells (Figure 
3.7). At 8 hpi IBDV infection induced high levels of AKT activation compared to 
mock. The PI3K inhibitor was able to supress the IBDV induced activation of AKT as 
expected, confirming the efficacy of the inhibitor and antibody in avian cells (Figure 
3.8C).  
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The effect of IBV infection on the PI3K/AKT signalling pathway in avian cells was 
then investigated. In contrast to mammalian cells where activation occurred after 6 
hpi, IBV was found to induce AKT activation in a biphasic manner in avian cells 
(Figure 3.9). An increase in pAKT S473 was seen at 2 hpi which was supressed by 
6 hpi. A second peak in AKT activation was then observed from 16 to 24 hpi.  A 
similar pattern was seen in phosphorylation of AKT at its T308 site (Figure 3.10). 
This biphasic activation has been previously reported for several mammalian viruses 
(Zhu et al., 2011a, Ehrhardt et al., 2006). In these studies, it is suggested that the 
early activation of AKT is a result of an antiviral response that is subsequently 
supressed by the virus. It is not clear however, whether the second phase of 
activation is a cellular response to the replication of the virus or a viral response to 
ensure cell survival. The second phase of activation during influenza infection is an 
anti-apoptotic signal induced by the virus (Ehrhardt et al., 2007). It may therefore be 
the case for IBV and this is investigated in Chapter 4. It is also not clear if the initial 
phase of activation and subsequent suppression is a result of viral activity or a 
cellular response to infection.  
The attachment of the virus to the cell is the earliest point at which cellular signalling 
pathways can be activated by a virion. It is the binding of the viral attachment protein 
to the cellular receptor embedded in the membrane that initiates signalling cascades 
within the cell. For example, HIV-1 is known to activate signalling pathways as early 
as 1 minute post infection (Wojcechowskyj et al., 2013). The avian reovirus is also 
known to activate AKT early during infection, from 15 mins to 4 hpi (Lin et al., 2010). 
The presence of PI3K/AKT signalling at the cellular membrane and early activation 
of AKT suggested that binding and entry of IBV may result in activation of the 
pathway. This was investigated using an inactivated form of the virus that was able 
to bind and enter the cell but not replicate (Figure 3.11). Activation of AKT was 
found to occur as a result of viral receptor binding and entry, but found to be 
independent of active replication (Figure 3.12). Activation of AKT by the inactivated 
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virus occurred from 30 mins to 1 hpi. Interestingly, AKT activation decreased again 
by 1 hpi suggesting that either the stimulus was no longer present or that this 
activation was suppressed. Due to the fact that levels of AKT activation during IBV-
WT infection continued to increase, it is more likely that the proteins in the BEI 
inactivated virus were degraded quickly and the stimulus lost. The binding of the 
virus to the cellular receptor may therefore be the initial activator of AKT. The 
treatment of virus with BEI may have affected the ability of the virus to attach and 
enter the cell and therefore there was less virus present to induce a prolonged 
activation of AKT as seen in the WT infections. Interestingly the early activation with 
the wild-type virus was not seen in mammalian cells. This suggests that avian 
cellular pathways are activated differently from mammalian cells during IBV 
infection. This may be due to different viral attachment receptors between the 
species. Alternatively, the entry mechanism of the virus in avian cells may be 
different to that in mammalian cells. Unfortunately, comparatively little is known 
about IBV entry compared to other coronaviruses.  The initial phase of AKT 
activation may be induced by the virus as a pro-viral response and the virus may not 
be able to produce this effect in mammalian cells. Interestingly IBV infection has 
been found to induce interferon-gamma production as early as 1 hpi in avian cells 
but not mammalian cells, suggesting that different pathways are activated in the two 
species (Ariaans et al., 2009).  
Specific inhibitors of cellular signalling pathways have been investigated as antiviral 
treatments against viruses such as Influenza (Planz, 2013). More specifically 
inhibition of PI3K/AKT signalling has previously been reported as a potential antiviral 
strategy for treatment of MERS-CoV (Kindrachuk et al., 2015, Josset et al., 2013). In 
this study the effect of PI3K/AKT inhibition on replication of IBV in avian cells was 
investigated (Figures 3.13-3.16). The inhibition of PI3K/AKT with LY294002 inhibited 
viral replication by suppression of viral genome replication and protein synthesis. 
Inhibition of PI3K resulted in a significant decrease in the amount of infectious virus 
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particles released. Interestingly levels of N-message mRNA did not change when 
the pathway was inhibited. However, the delay in spike protein production suggests 
that the results seen here are not representative of all mRNAs and may be specific 
to the N-message.  Coronavirus proteins are synthesised from a set of nested sub-
genomic mRNA that are transcribed in a discontinuous manner (Sawicki et al., 
2007). As N is involved in the formation of the nucleocapsid and protection of the 
viral genome, it may be translated in higher amounts than other messages. There 
has been evidence for the requirement of sustained replication of the nucleocapsid 
protein for optimal replication of coronaviruses (Almazan et al., 2004).  
The site of IBV RNA synthesis is yet to be identified. However, the viral replicase 
proteins of other coronaviruses, such as SARS-CoV, have been found to associate 
with cellular membranes such as the ER and the formation of double-membrane 
vesicles (Snijder et al., 2006). A previous study identified IBV-induced membrane 
rearrangements similar to those seen in other positive strand virus infections but not 
in other coronaviruses (Maier et al., 2013b). These include double-membrane 
vesicles and zippered-ER with attached spherules. These novel membrane re-
arrangements were identified during IBV infection of Vero and primary CK cells as 
well as ex-vivo tracheal organ cultures. However, in this study both double-
membrane vesicles and spherules connected to zippered-ER were observed (Figure 
3.17). The novel membrane structures were hypothesised to be the site of viral RNA 
synthesis. The suppression of viral replication by PI3K/AKT inhibition, and the role of 
the PI3K/AKT in many cellular processes, may implicate the pathway in the 
formation of these novel membrane structures. The effect of PI3K activation on the 
formation of the membrane structures during IBV infection was therefore 
investigated. No qualitative change was observed in the structure or number of 
vesicles over three separate samples in the presence of LY294002. This suggests 
that either PI3K/AKT signalling has no role in the formation of the membrane 
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structures during IBV replication, or that the novel structures identified by Maier et al 
(2013) are not the site of viral RNA synthesis.  
The effect of various IBV structural proteins on PI3K/AKT signalling has been 
investigated. Overexpression of the IBV M protein was observed to stimulate the 
activation of AKT consistently in each replicate. However, overexpression of the E 
and S proteins did not consistently alter levels of AKT expression. The 
overexpression of IBV N protein reduced levels of AKT activation in 4 out of 5 
replicates. The effect of various coronavirus proteins on PI3K/AKT signalling has 
previously been studied. For example, the SARS-CoV M protein has been found to 
modulate the PI3K/AKT signalling pathway to induce apoptosis (Tsoi et al., 2014). 
Whilst this may be the case for IBV, the SARS-CoV M protein was found to down-
regulate AKT phosphorylation to induce apoptosis. The expression of SARS-CoV N 
protein has also been found to down-regulate AKT and induce apoptosis (Surjit et 
al., 2004). None of the structural proteins produced a large increase in AKT 
phosphorylation, compared to whole virus, indicating that there may be several viral 
proteins acting in concert to modulate the PI3K/AKT signalling.  
Together, this data indicates an important role of PI3K/AKT signalling in IBV 
replication and suggests a complicated interplay between the modulation of 
signalling pathways by the virus and the host cell.  
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3.8 Chapter Summary 
IBV infection of mammalian cells: 
 Induces AKT activation from 12 to 24 hpi 
 AKT activation at 24 hpi is dependent on PI3K activity 
 
IBV infection of avian cells: 
 Induces a biphasic activation of AKT at 2 hpi and then from 16 to 24 hpi 
 The later phase of AKT activation, from 16 to 24 hpi, occurs in a PI3K-
dependent manner 
 Viral binding and entry is sufficient to induce the initial phase of AKT 
activation 
 Virus replication requires an active PI3K/AKT signalling pathway  
Overexpression of IBV membrane protein may stimulate AKT activation 
 
3.7 Future work 
The cellular furin content of different cell lines is thought to be a factor in the 
susceptibility of avian and mammalian cells to IBV infection (Tay et al., 2012). It 
would therefore be interesting to study this interaction by measuring levels of furin in 
different cell lines and correlating this to their susceptibility to IBV infection. By 
overexpressing furin in HD11 cells which are known to not be susceptible to IBV, we 
could elucidate the importance of furin in establishing infection.  Whilst dsRNA is a 
good indicator of viral infection, qPCR assays are more sensitive and efficient. It 
would therefore be beneficial to repeat the cellular tropism study using qPCR of 
genomic and sub-genomic RNA.  
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The biphasic activation of AKT has been previously reported for Influenza where it 
was suggested that the first phase of AKT activation was a cellular response to 
initial infection (Ehrhardt et al., 2006). The suppression of AKT activity was thought 
to be a pro-viral response to ensure cell survival. This may be the case for IBV 
however further studies need to be conducted to assess the basis of the AKT 
modulation during infection. The effect of PI3K inhibition on the early phases of AKT 
activation was not consistent. It would therefore be beneficial to look at levels of 
PI3K activation during the initial stages of infection using a PI3K specific antibody. 
This would elucidate the relationship between PI3K and AKT at these early stages 
of the viral life cycle. Likewise, it would be interesting to look at levels of PI3K 
activation in mammalian cells during infection to see whether at the earlier time 
points PI3K was activated.  
An inactivated form of the virus was able to activate AKT up to 1 hpi. It is therefore 
possible that this initial phase of AKT activation is a result of binding of the virus to 
avian cellular receptors. The cellular receptors for IBV are unknown, however it 
would be interesting see if binding of the virus to the cell was sufficient to induce 
AKT activation. This could be done by incubating the cells with virus on ice to 
prevent entry. As BEI inactivation involves diluting the virus stock, a UV inactivated 
virus could be produced which would allow us to incubate the cells in the same 
number of virus particles as wt-IBV.  
The finding that inhibition of PI3K, by LY294002, significantly reduced the ability of 
IBV to replicate in avian cells was interesting. This could be further investigated by 
siRNA knockdown of key PI3K/AKT regulators such as PDK1 and PIP3, although 
this may be lethal to the cell. This finding also provides us with potential candidates 
for antivirals against IBV. Other AKT inhibitors such as MK2206 have been 
recommended for use as antiviral treatments (Denisova et al., 2014). 
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The overexpression of IBV M and N proteins were found to modulate AKT activation 
(Figure 3.18/19). The IBV M protein was found to increase AKT phosphorylation, 
and the N protein to down regulate it. This needs to be investigated further by 
examining the interactions of the viral proteins with cellular factors. For example, the 
C-terminus of the SARS-CoV membrane protein is known to interact with the PH 
domain of PDK1. Therefore, the effect of M and N overexpression of PDK1 and 
PI3K could initially be investigated by western blot. Protein pull downs or 
immunofluorescence co-localisation studies could then be performed to identify if 
there is an interaction between the avian PDK1 and the IBV membrane or 
nucleocapsid proteins. It is possible that several of the viral proteins are involved in 
modulation of PI3K/AKT signalling. For example, several of the coronavirus non-
structural proteins (nsps) have been found to modulate cellular pathways. Therefore, 
the effect of nsp deletion mutants on AKT activation could be assessed. Mass 
spectrometry could also be employed to identify the interaction partners of key 
pathway proteins such as PI3K.   
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4.1 Introduction 
The effect of IBV infection on the PI3K/AKT signalling pathway was investigated in 
Chapter 3. IBV was found to induce AKT activation in a biphasic manner in avian 
cells, and replication of the virus was found to be reliant on an active PI3K/AKT 
signalling pathway. In this chapter the downstream effects of PI3K/AKT activation 
during IBV infection are investigated. Many viruses modulate the pathway to aid viral 
replication. For example, several structural proteins of the SARS-CoV are known to 
induce apoptosis in Vero cells through the down-regulation of AKT phosphorylation 
(Surjit et al., 2004, Chan et al., 2007). Some avian viruses have been found to 
modulate apoptosis via PI3K/AKT, including Newcastle disease virus (Ravindra et 
al., 2008a, Ravindra et al., 2008b) and avian reovirus (Lin et al., 2010). IBV also 
modulates caspase-dependent apoptosis in Vero cells (Liu et al., 2001), however 
the pathway by which this occurs is still not fully elucidated and few studies have 
been performed in avian cells.  
As well as apoptosis, other downstream pathways are known to be modulated 
through PI3K. For example, the mTOR pathway involved in cell growth, autophagy 
and mRNA translation is also involved in viral replication. Porcine Respiratory and 
Reproductive Syndrome Virus (PRRSV) targets the PI3K/AKT signalling pathway to 
induce autophagy through mTOR signalling (Pujhari et al., 2014). Lentiviruses also 
modulate mTOR signalling by down regulating PI3K, AKT and 4E-BP1 (Du et al., 
2014).  Few studies examining the interaction between avian viruses and the mTOR 
pathway have been performed. Although recent studies in Vero cells have identified 
activation of autophagy during IBV replication, the same did not occur in avian DF1 
cells. Interestingly, however, when expressed alone, nsp6 was able to induce 
autophagy in both Vero and DF1 cells (Cottam et al., 2011). Again, whilst various 
signalling pathways are activated during IBV infection, the exact mechanism by 
which they occur is still unknown.  
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Another downstream pathway, often regulated by PI3K/AKT signalling, is 
macropinocytosis. Many viruses utilise the macropinocytosis pathway to enter the 
cell. For example the filamentous form of Influenza virus enters the cell via 
macropinocytosis (Rossman et al., 2012). African Swine Fever and Nipah Viruses 
have also been found to use the same mechanism (Pernet et al., 2009, Sanchez et 
al., 2012). Recently, a role for the pathway that is independent of entry has been 
suggested as a result of CoV replication (Freeman et al., 2014). In the case of MHV, 
macropinocytosis signalling has been implicated as a tool for the recruitment of 
membranes and nutrients into infected cells and syncytia formation. No studies to 
date have investigated the involvement of macropinocytosis in IBV infection.  
 
In this chapter the effect of IBV infection on downstream processes controlled by the 
PI3K/AKT signalling pathway including, apoptosis, mRNA translation and 
macropinocytosis are investigated. 
 
4.2 Apoptosis 
Previous studies have investigated the effect of IBV infection on the apoptotic 
signalling pathway in Vero cells (Liu et al., 2001, Li et al., 2007). To confirm their 
findings, the cleavage of caspase 3 and 7 was measured by a luciferase 
luminescent assay (Methods section 2.7.2). Vero cells were mock infected or 
infected with IBV and at 1, 6, 12 and 24 hpi and the amount of caspase cleavage 
was measured by luciferase assay (Figure 4.1). Caspase cleavage was seen at 1 
hpi however, levels in mock samples increased at 6 hpi. From 12 to 24 hours levels 
of caspase cleavage were higher in the infected cells (p<0.002 & 0.005 
respectively).  
The effect of IBV infection on apoptotic signalling was subsequently investigated in 
avian DF1 cells. The efficacy of the caspase cleavage luminescent assay in avian 
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cells was initially determined by treatment of DF1 cells with a known activator of 
apoptosis, staurosporine. DF1 cells were treated with 0.01 mM staurosporine and 
the amount of caspase cleavage measured by luciferase assay at 2, 6, 12, 18 and 
24 hours post stimulation (Figure 4.2). Staurosporine induced caspase cleavage in 
DF1 cells from 6 hpi with a sharp increase from 12 to 18 hpi.  Subsequently, the 
effect of IBV infection on the apoptotic pathway was investigated. DF1 cells were 
mock infected or infected with IBV and levels of caspase cleavage measured at 2, 6, 
12, 18, 24 and 36 hpi (Figure 4.3). An initial period of caspase cleavage was 
observed at 2 hpi which was suppressed again by 6 hpi to 24 hpi. From 24 hpi to 36 
hpi a significant increase in caspase cleavage was seen in IBV infected cells 
(p<0.005).   
The apoptotic signalling pathway can be regulated upstream by the anti-apoptotic 
PI3K/AKT signalling pathway. To determine whether PI3K/AKT signalling was 
involved in the modulation of apoptosis during IBV infection, DF1 cells were infected 
with IBV in the presence or absence of LY294002, a specific PI3K inhibitor. At 2, 6, 
12, 18, 24 and 36 hpi levels of caspase 3/7 cleavage were measured (Figure 4.4). 
Inhibition of PI3K with LY294002 resulted in no significant change in caspase 3/7 
cleavage at any time point during IBV infection.  
Whilst caspase 3/7 cleavage is a good indicator of apoptosis, it occurs early in the 
pathway and several factors may be employed further downstream to inhibit or 
induce apoptosis. Therefore, the effect of IBV infection on the apoptotic pathway 
was also measured by labelling with Annexin V that binds to phosphatidyl-serine 
(PS). PS translocates to the outside of the plasma membrane during apoptosis and 
so, with propidium iodide (PI) labelling, flow cytometry can be used to measure the 
amount of early and late apoptosis occurring in a population of cells.  
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DF1 cells were either mock infected, infected with IBV or treated with staurosporine 
and labelled with Annexin V-FITC and PI at 24 hpi. The flow cytometry data for the 
mock infected, staurosporine treated and IBV infected samples are attached in 
appendix 1, 2 and 3 respectively. For ease of analysis the percentage of live cells 
(FITC negative, PI negative), cells in early apoptosis (FITC positive, PI negative), 
late apoptosis (FITC positive, PI positive) and necrotic cells (FITC negative, PI 
positive) are plotted for each treatment (Figure 4.5). The percentage of cells in early 
apoptosis increases significantly from 6% in mock to 24% in staurosporine treated 
cells (p<0.0001) (Figure 4.5A). The percentage of cells undergoing early apoptosis 
in IBV infected cells does not change significantly from mock levels. The percentage 
of cells in late apoptosis or undergoing necrosis was also measured (Annexin V-
FITC positive, PI positive) (Figure 4.5B). A smaller increase in the percentage of 
cells in late apoptosis/necrosis was observed in DF1 cells treated with staurosporine 
compared to early apoptosis. However, no change was seen in IBV infected cells at 
24 hpi.  
4.3 GSK-3β 
The role of glycogen synthase kinase-3β (GSK-3β) in cellular pathways is 
widespread. It is involved in a variety of functions such as differentiation, growth, 
motility, cell cycle progression, apoptosis and the insulin response. Phosphorylation 
at the S9 site by kinases, including AKT, results in inactivation. The effect of IBV 
infection on phosphorylation of GSK-3β at S9 was determined by western blot.   
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DF1 cells were mock infected or infected with IBV in the presence or absence of the 
PI3K inhibitor LY294002. At 2, 6, 12 and 24 hpi cells were lysed and proteins 
separated by SDS-PAGE. Proteins were transferred onto a membrane and probed 
with anti-pGSK-3β S9 and anti-β-actin (Figure 4.6A). Analysis of the western blot 
suggests an increase in GSK-3β S9 phosphorylation during infection compared to 
mock at 2 hpi (Figure 4.6B). At 24 hpi there is an increase in GSK-3β 
phosphorylation in mock infected cells that was unexpected. At 2, 6 and 12 hpi 
inhibition of LY294002 results in a decrease in GSK-3β S9 phosphorylation 
suggesting a dependency on an active PI3K/AKT signalling pathway. At 24 hpi the 
results from the three replicates were inconsistent with two out of three replicates 
having higher levels of GSK-3β phosphorylation in the mock sample.  
4.4 Cap-dependent translation 
The activation of the PI3K/AKT/mTOR signalling cascade by growth factors, 
cytokines and hormones is known to induce cap-dependent translation (Gingras et 
al., 1998). The 4E-BPs, in their hypo-phosphorylated state, bind to and inhibit the 
interaction of eIF4E and the eIF4F complex (Pause et al., 1994). Activated 
PI3K/AKT/mTOR signalling facilitates phosphorylation of the 4E-BPs to inhibit its 
interaction with eIF4E and therefore allows cap-dependent translation to occur.  
DF1 cells were mock infected or infected with IBV in the presence or absence of the 
PI3K inhibitor LY294002. At 2, 12 and 24 hpi cells were lysed and proteins 
separated by SDS-PAGE. Proteins were transferred onto a nitrocellulose membrane 
and labelled with anti-p4E-BP1 T37/46 and anti-β-actin (Figure 4.7A). Analysis of 
shows suppression of 4E-BP1 phosphorylation in mock infected cells when PI3K is 
inhibited at 2 hpi (Figure 4.7B). Densitometry also suggests that IBV infection may 
induce 4E-BP1 phosphorylation in DF1 cells at 2, 12 and 24 hpi. The 
phosphorylation appeared to be dependent on active PI3K with levels of p4E-BP1 
T37/46 supressed when the cells were treated with LY294002.  
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The phosphorylation of 4E-BP1 at T37/46 is known to prime the protein for 
phosphorylation at the T70 and S65 sites (Gingras et al., 1999). Therefore, the 
same lysates were probed with anti-p4E-BP1 T70 and S65, along with anti-β-actin 
(Figure 4.8). The antibodies were used at a 1:1000 however neither of the 
phosphorylated versions of the protein were bound by the antibodies.  
4.5 Macropinocytosis 
MHV is known to activate macropinocytosis in an entry-independent manner. The 
ability of IBV infection to induce macropinocytosis was therefore investigated. 
Macropinocytosis involves actin re-arrangement and is characterised by bulk fluid 
uptake. Phorbol esters such as phorbol myristate acetate (PMA) increase the rate of 
bulk fluid uptake and the abundance of macropinosomes in a PI3K dependent 
manner (Araki et al., 1996, Yoshida et al., 2015). Several methods are available for 
studying the macropinocytosis in cells, however none of the methods had been 
tested in avian cells. A method for establishing levels of macropinocytosis in avian 
cells was therefore investigated. Initially the ability of PMA to induce actin re-
arrangement, as a measure of macropinocytosis, was measured in Vero cells. Vero 
cells were treated with 400 nM PMA or the equivalent volume of DMSO diluted in 
media as a control. After 30 minutes the cells were washed and fixed. Actin was 
then stained with Phalloidin 568 and the nuclei with DAPI (Figure 4.9). The 
arrangement of actin within the control cells is defined along the plasma membrane 
(Figure 4.9A). However, when treated with PMA, the plasma membrane became 
less defined as cell wide actin re-arrangement occurred (Figure 4.9B). This 
demonstrates the efficacy of PMA in inducing actin re-arrangement in Vero cells. 
Whilst actin re-arrangement was identified during PMA stimulation, infection of cells 
with IBV did not results in any obvious membrane re-arrangement or membrane 
ruffling (Figure 4.10). This suggests that either IBV does not induce 
macropinocytosis in Vero cells or that membrane ruffling is not a good indication of 
the macropinocytic activity in these cells.  
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Therefore, another assay, to measure levels of micropinocytosis, was tested on 
Vero cells. Along with actin re-arrangement, bulk-fluid uptake is another indicator of 
macropinocytosis. To measure levels of bulk fluid uptake in DF1 cells, 800 nm 
fluorescently labelled polystyrene nanoparticles were added to the cell culture 
media. The particles were too large to be taken up by endocytosis but small enough 
to be engulfed in a macropinosome (Lim and Gleeson, 2011). Cells were incubated 
in 1 μg/ml fluorescently labelled nanoparticles for 24 hours. After 24 hrs, cells were 
washed in PBSa and fixed. Actin was labelled with Phalloidin 568 and nuclei with 
DAPI (Figure 4.11). Several cells had nanoparticles present on the plasma 
membrane (indicated with * Figure 4.11). Others had internalised nanoparticles 
(indicated with + Figure 4.11). The location of the nanoparticles within the cell was 
confirmed by scanning through the z-axis of each cell. The effectiveness of PMA to 
induce bulk fluid uptake in Vero cells was then investigated using the fluorescently 
labelled nanoparticles. Cells were incubated with the nanoparticles for 1 hour prior 
to treatment with various concentrations of PMA. The cells were incubated with PMA 
for 1 hour and then fixed and stained with Phalloidin 568 and DAPI. At 200 nM an 
increase in the percent of cells containing internalised nanoparticles was seen from 
41% to 79% (p<0.02). At 400 nM, PMA induces actin re-arrangement (Figure 4.12) 
and an increase in the percentage of nanoparticle internalisation was observed from 
41% to 91% of cells at that concentration. The large amount of variation and 
inconsistency throughout the replicates suggested that further controls needed to be 
employed in order to for this protocol to be used.  
The effect of the macropinocytosis inhibitor Amiloride was then investigated. Vero 
cells were incubated in different concentrations of Amiloride for 24 hours. After 24 
hours the cytotoxicity of the inhibitor was determined by luminescent cell titre assay 
(Figure 4.13). The addition of Amiloride at 0.5 μM was found to cause no significant 
drop in cell titre however increasing the concentration to 1 μM decreased the 
luminescence output from 2x107 to 8.3x106 RLU.  
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To establish the efficacy of Amiloride as a macropinocytosis inhibitor at 0.5 μM, 
Vero cells were incubated in nanoparticles and pre-treated with Amiloride or an 
equivalent volume of DMSO for 1 hour.  Cells were also incubated in LY294002 to 
determine if PI3K was involved in this signalling pathway. After 1 hour, cells were 
stimulated with PMA or the equivalent volume of DMSO for another hour. Cells were 
then washed, fixed and actin stained with Phalloidin 568 and the nuclei with DAPI. 
The percentage of cells containing at least one internalised nanoparticle was 
determined for each condition (Figure 4.14). Whist a decrease in the percentage of 
cells with internalised nanoparticles was seen during both PI3K and 
macropinocytosis inhibition, neither of these results were statistically significant. The 
stimulation of control cells with PMA was not seen to induce a significant increase in 
nanoparticle internalisation in this experiment either.  
The effect of IBV infection on the internalisation of nanoparticles was also 
investigated. Cells were incubated in the fluorescent nanoparticles for an hour and 
then either mock infected or infected with IBV. At 2, 6, 12 and 24 hpi cells were fixed 
and actin stained with Phalloidin 568, and the nuclei with DAPI. The percentage of 
cells containing at least one nanoparticle was calculated (Figure 4.15). At 2 hpi there 
was a significant increase in nanoparticle uptake between the mock infected and 
infected cells, from 8% to 34% (p=0.03). There was no significant change in 
nanoparticle uptake at any other time point. However, due to the lack of an 
appropriate positive and negative control, this data could not be confirmed.  
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4.6 Discussion 
Apoptosis has been reported to occur in IBV infected Vero cells by using terminal 
deoxynucelotidyl transferase dUTP nick end labelling (TUNEL) assay (Liu et al., 
2001, Li et al., 2007). Whilst the TUNEL assay is often used for reporting levels of 
apoptotic activity, it may not allow for the differentiation between necrotic and 
apoptotic cells. Liu et al (2001) then went on to confirm the involvement of caspase 
in IBV induced apoptosis of mammalian cells using a specific caspase inhibitor z-
VAD-FMK. This study provides results that suggest a similar response in avian cells. 
Interestingly, an early activation of caspase 3/7 in Vero cells was observed, 
suggesting that activation of apoptosis also occurs in a biphasic manner.  
The effect of IBV infection on the apoptotic pathway was then investigated in avian 
cells. Staurosporine, a known activator of apoptosis, induced caspase 3/7 cleavage 
in DF1 cells from 6 to 24 hpi (Figure 4.2). IBV infection was also found to induce 
caspase 3/7 cleavage above mock levels at 2 hpi and then subsequently from 24 to 
36 hpi (Figure 4.3). A similar pattern of caspase cleavage was seen in IBV infected 
Vero cells, however in DF1 cells activation of caspase cleavage is delayed until 24 
hpi. Interestingly IBV infection of both Vero and DF1 cells results in an increase in 
caspase cleavage at 2 hpi that is subsequently supressed by 6 hpi. This is 
potentially an antiviral response that is subsequently supressed by viral factors. The 
rotavirus for example, supresses viral-induced cellular apoptosis to facilitate viral 
growth (Bagchi et al., 2010). The increase in caspase cleavage correlates with an 
increase in AKT activation seen in Chapter 3 (Figure 3.10) suggesting a role of the 
PI3K/AKT signalling pathway in pro-apoptotic responses.  
The effect of PI3K inhibition by LY294002 on caspase 3/7 cleavage was 
investigated. Levels of caspase 3/7 cleavage induced by IBV infection were not 
altered by inhibition of PI3K (Figure 4.4). This suggests that the PI3K/AKT signalling 
pathway is not involved in IBV induced apoptosis in DF1 cells. A previous study 
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presented evidence of ER stress during IBV infection of mammalian cells (Fung et 
al., 2014). ER stress is known to induce apoptosis through cleavage of caspase 9 
and then subsequently signalling through the caspase 3,6 and 7 complex. It is 
therefore possible that the cleavage of caspase 3/7 seen in Figure 4.3 is a result of 
an ER stress response. The independence of this activation from PI3K/AKT activity 
supports this hypothesis, as the ER stress/apoptosis pathway does not involve 
PI3K/AKT activation. Fung et al (2014) also suggest that the IBV-induced ER stress 
response triggers the anti-apoptotic IRE1α, which in turn modulates pro-survival 
responses via JNK and AKT. This may be an explanation for the activation of the 
PI3K/AKT signalling pathway. Replication of viral proteins may induce ER stress, 
resulting in the activation of the pro-apoptotic pathway and cleavage of caspase 3/7. 
The virus may then modulate pro-survival pathways such as AKT through IRE1α, 
preventing apoptosis.  
Whilst IBV infection of DF1 cells was found to induce caspase cleavage, it was not 
found to induce the translocation of PS to the outside of the plasma membrane, 
another marker of apoptosis. The signals underlying the externalisation of PS during 
apoptosis are unknown, however it is generally assumed that it occurs as a 
consequence of caspase cleavage (Huigsloot et al., 2001). In the case of IBV 
infection of avian DF1 cells, caspase 3/7 cleavage may occur in the absence of PS 
externalisation. Since PS externalisation occurs as a result of a pro-apoptotic 
pathway, a factor downstream of the caspase complexes may be inhibiting 
apoptosis during IBV infection. Alternatively, due to the fact that PI3K inhibition does 
not alter caspase 3/7 cleavage, the anti-apoptotic PI3K/AKT signalling pathway may 
be acting downstream of the caspase complex to supress apoptosis. Many viruses 
are known to induce apoptosis through caspase activation. For example, the 
Influenza virus induced caspase-dependent apoptosis, however no viruses have 
been noted to induce caspase activation without the triggering of PS externalisation 
(Takizawa et al., 1999).  
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The role of GSK-3β in many cellular processes, and its position downstream of AKT, 
suggested that it may be modulated during IBV infection. Among other pathways, 
GSK-3β is known to have a pro-apoptotic function where it indirectly activates p53 
and Bax to induce the caspase cascade. An increase in caspase 3/7 cleavage 
during IBV infection was previously shown to be independent of PI3K activity (Figure 
4.4). The PI3K dependent inhibition of GSK-3β during infection, suggests that the 
cleavage of caspase 3/7 also be GSK-3β independent and a cellular anti-viral 
response occurring independently of PI3K/AKT signalling (Figure 4.6). The de-
activation of GSK-3β by phosphorylation at S9 may therefore be a pro-viral 
response elicited by the virus in an attempt to counteract the cellular pro-apoptotic 
response.  
GSK-3β has also recently been found to be involved in the modulation of antiviral 
activity by the zinc-finger antiviral protein (ZAP) (Sun et al., 2012). The antiviral ZAP 
is a host factor that is known to inhibit the replication of HIV-1 (Zhu et al., 2011b) 
and alphaviruses such as Sindbus virus (Zhang et al., 2007). GSK-3β was found to 
enhance the activity of ZAP by phosphorylation at specific sites (Sun et al., 2012). It 
is therefore possible that the PI3K-dependent inactivation of GSK-3β is a pro-viral 
response to prevent ZAP from targeting viral mRNA and therefore inhibiting viral 
replication. This may also suggest why inhibition of PI3K was found to reduce 
genome replication, viral protein production and infectious virus particle release.  
Cellular mRNA is recognised by the cap-binding protein eIF-4E which exists as part 
of the eIF-4F complex. The binding of the cap-binding protein facilitates unwinding 
of the mRNA 5' secondary structure and allows attachment of the 40s ribosomal 
subunit. The 4E-BPs are translational repressors that act by attaching to the eIF-4E 
complex. Growth factors and hormones activate protein translation by 
phosphorylation and inactivation of the eIF4E-binding proteins. The 4E-BPs are 
phosphorylated and therefore inactivated by the PI3K/AKT/mTOR signalling 
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cascade allowing translation to occur (Gingras et al., 1998). The deactivation of 4E-
BPs occurs initially by phosphorylation at T37/46 which primes the protein for 
subsequent phosphorylation at T70 and S65.  Unfortunately, the antibodies for p4E-
BP1 T70 and S65, raised against mammalian proteins, did not cross-react with the 
avian DF1 cells. Due to a lack of time, the assay was not repeated on mammalian 
cells. However, p4E-BP1 at T37/46 was detected by western blot. An increase in the 
phosphorylation of 4E-BP1 at T37/46 was observed at some time points during IBV 
infection, which appeared to be dependent on PI3K activity. The protocol however 
requires further adjustments as the data is inconsistent.  
In Chapter 3, IBV infection was seen to induce AKT activation at 2 hpi and then 
subsequently from 16 hpi to 24 hpi (Figure 4.7). The PI3K dependency of the 4E-
BP1 phosphorylation and the activation of AKT seen at these time points suggests 
that phosphorylation of 4E-BP1 may be induced via the PI3K/AKT signalling 
pathway. The effect of LY294002 on the growth of the virus was investigated in 
Chapter 3 and it was found that inhibition of PI3K reduced viral genome replication, 
protein synthesis and release of infectious virus particles. This suggests that by 
inhibiting PI3K, the IBV induced phosphorylation of 4E-BP1 could be hindered, 
therefore inhibiting cap-dependent translation. That, in turn, may have a knock-on 
effect on protein synthesis and release of infectious virus particles. The role of the 
modulation of translation during viral replication is often multi-faceted. For example, 
the respiratory syncytial virus was found to modulate translation via de-
phosphorylation of 4E-BP1 (Pérez-Gil et al., 2015). However, it was recently found 
that stress granules were formed in cells infected with RSV and that the presence of 
the granules did not alter viral replication (Lindquist et al., 2010). This suggests that 
the virus is able to control processes that allow the replication of viral proteins 
despite the cell being under stress. The PI3K dependent activation of AKT, 
subsequent phosphorylation of 4E-BP1 T37/46, and activation of cap-dependent 
translation during IBV infection, is therefore hypothesised to be a pro-viral response 
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induced by the virus. Interestingly, the replication of other coronaviruses has been 
found to be dependent on eIF4E-eIF4G interactions (Cencic et al., 2011).   
Macropinocytosis is an actin-dependent process that involves the non-selective 
uptake of molecules, nutrients and antigens. The large size of macropinosomes 
allows the uptake of viruses such as the nipha virus (Pernet et al., 2009), influenza 
virus (Rossman et al., 2012), African swine fever virus (Sanchez et al., 2012) and 
foot-and-mouth disease virus (Han et al., 2016). MHV was found to induce 
macropinocytosis in an entry-independent manner (Freeman et al., 2014). There is 
increasing evidence that the PI3K/AKT signalling pathway is involved in the 
regulation of macropinosome formation through Ras and PIP3. Ras is known to 
induce PIP3 through binding to PI3K, and the attenuation of PIP3 results in the 
inhibition of macropinocytosis (Rodriguez-Viciana and Downward, 2001, Araki et al., 
1996). AKT is then subsequently recruited to macropinosomes by PIP3 along with 
other effector molecules containing PH-domains (Rupper et al., 2001). The role of 
the PI3K/AKT signalling pathway in IBV infection seen in Chapter 3 suggested that 
the macropinocytosis pathway may be involved. However, methods employed to 
measure macropinocytosis have not been extensively tested in avian cells. Initially 
the ability of PMA to stimulate actin re-arrangement in Vero cells was assessed in 
order to optimise the assays prior to testing in DF1 cells.  PMA was found to induce 
actin re-arrangement (Figure 4.9) however no visible change actin arrangement was 
seen in IBV infected cells at 24 hpi (Figure 4.10). The assessment of actin re-
arrangement was deemed too subjective and therefore a more quantitative assay 
was tested. The level of bulk fluid uptake was assessed by the addition of 
fluorescent nanoparticles to the media (Figure 4.11). The fluorescently labelled 800 
nm polystyrene nanoparticles were previously used by Freeman et al (2014) in the 
study of macropinocytosis during MHV infection. An average of 42% of the mock 
infected cells were found to contain at least one internalised nanoparticle. This was 
a lot higher than expected as levels of particle uptake in the mock infected DBT cells 
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from the Freeman et al (2014) paper were below 10%, increasing to 40% during 
infection with MHV and SARS-CoV. At a concentration of 400 nM PMA, increased 
nanoparticle uptake into cells was observed (Figure 4.12). However, the replicates 
were highly variable. A known inhibitor of macropinocytosis, Amiloride was then 
assessed for its efficacy in Vero cells. It was found to not be cytotoxic at 0.5 μM 
(Figure 4.13) but did not significantly reduce nanoparticle uptake in control or PMA 
stimulated cells (Figure 4.14). As the macropinocytosis pathway is known to be 
dependent on PI3K/AKT signalling, the same experiment was performed using the 
PI3K inhibitor LY294002. As with Amiloride, LY294002 did not significantly inhibit 
nanoparticle uptake in either the control or PMA stimulated cells (Figure 4.14). 
However in the experiments performed in the presence of Amiloride and LY294003, 
PMA did not significantly induce nanoparticle uptake and again the individual 
replicates were highly variable. The fact that PMA was not able to induce 
nanoparticle uptake in these experiments but was able to in earlier experiments 
suggested that the assay was highly susceptible to slight variations in cell 
confluency and passage number. Whilst every attempt was made to ensure that the 
confluency of the cells was the same in each replicate, the density of the cells in 
different areas of the coverslip may also have resulted in these errors. Despite this 
there is a general trend in each replicate suggesting a suppression of nanoparticle 
internalisation in the presence of LY294002 compared to control and even more so 
with Amiloride.  
The protocol was also tested on IBV infected mammalian cells (Figure 4.15).  A 4 
fold increase in the number of cells containing nanoparticles was seen at 2 hpi but 
not at 6, 12 or 24 hpi. These results were again the average of three fields of view 
from three different coverslips. However only cells displaying infection (as 
determined by dsRNA staining), or those immediately adjacent to the infected cells 
were counted. This may have resulted in less variability in the data. A general trend 
of an increase in nanoparticle uptake during IBV infection was seen at each time 
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point except 12 hpi. The increase in macropinocytosis seen at 2 hpi does not 
coincide with increases in PI3K activation that are only observed from 6 hpi in Vero 
cells. Due to the lack of nanoparticle internalisation at the later infection time points, 
the involvement of PI3K/AKT activation in macropinocytosis in Vero cells was not 
thought to be likely. The experiment was not repeated in DF1 cells due to time 
restraints. However, the highly variable nature of the assay in these cells suggested 
that it would be unlikely to be successful in the less consistent DF1 cell line.  
 
4.7 Summary 
Apoptosis 
 IBV infection results in caspase 3/7 cleavage at early and late phases of 
infection in avian and mammalian cells 
 IBV-induced caspase 3/7 cleavage is not dependent of active PI3K 
 Externalisation of PS does not occur during IBV infection of DF1 cells at 24 
hpi 
GSK-3β 
 GSK-3β is phosphorylated at S9 early during IBV infection and in a PI3K-
dependent manner 
Cap-dependent translation 
 4E-BP1 is phosphorylated at T37/46 late during IBV infection in a PI3K-
dependent manner 
Macropinocytosis 
 Bulk fluid uptake is induced in Vero cells at 2 hpi with IBV 
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4.8 Future Work 
The effect of PI3K inhibition on caspase 3/7 cleavage was investigated however, its 
effect was not determined on levels of PS externalisation. It would be interesting to 
investigate if inhibition of PI3K or AKT lead to an increase in PS externalisation, 
therefore implicating the pathway in suppression of apoptosis downstream of 
caspase 3/7 cleavage. Apoptosis has been previously identified to occur as a result 
of ER stress during IBV infection. It would be of interest to investigate whether the 
inhibition of IRE1α altered the activation of the PI3K/AKT signalling pathway. Also, 
by measuring caspase-12 cleavage, the origin of the pro-apoptotic response could 
be distinguished.  
The activity of the mTOR pathways was not investigated in this chapter. However, it 
would be interesting to measure levels of mTOR activity and to investigate its 
susceptibility to PI3K and AKT inhibitors to confirm the presence of the 
PI3K/AKT/mTOR signalling cascade in chickens. Should the activity of the signalling 
cascade be confirmed, it would be interesting to investigate the hypothesis that the 
phosphorylation of 4E-BP1 is a pro-viral response elicited by the virus. This could be 
done by specifically inhibiting various elements of the pathway, such as AKT 
activation, mTOR activation and the formation of the eIF4F translation initiation 
complex. During inhibition the amount of viral genome, mRNA and protein 
production as well as the release of infectious virus particles could be measured.   
Possible methods for determining levels of macropinocytosis during IBV infection 
were investigated in this chapter. The experiments were originally tested in Vero 
cells. However due to the high workload involved and a lack of time, the 
experiments were not repeated in DF1 cells. It would be interesting to do so. The 
nanoparticle assay was time consuming and involved the processing of large 
amounts of data. The apparent sensitivity of the assay lead to large variations in 
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replicates. Therefore, another method for measuring macropinocytosis could be 
investigated. By incubating the cells in a fluorescently labelled hydrophilic dye such 
as Dextran the amount of bulk fluid uptake can be measured by flow cytometry 
(Wang et al., 2014a). Using a marker for IBV infection it would be possible to 
selectively measure bulk fluid uptake in infected and uninfected cell populations by 
flow cytometry. This would allow large amounts of data to be processed easily and 
cells infected with IBV could be selected from the population for analysis.   
The interaction between GSK-3β and the apoptosis pathway during IBV infection 
was interesting and something that could be followed up. GSK-3β is known to not 
only be pro-apoptotic but also anti-apoptotic in the right conditions (Jacobs et al., 
2012). The effect of GSK-3β inhibition on caspase cleavage and apoptosis could 
therefore be investigated. This could be done using GSK-3β inhibitors such as 
Anilino maleimides that are known to specifically inhibit GSK-3β.  
Further studies should also be conducted to look at the role of ZAP in IBV infection. 
To date there have been no studies examining the effect of ZAP on coronaviruses. It 
may be interesting to measure levels of ZAP phosphorylation during infection and 
see if it alters with inhibition of GSK-3β.  
The downstream effects of AKT activation during IBV infection are varied and most 
likely extensive. Whilst apoptosis, cap-dependent translation and macropinocytosis 
have been investigated and discussed, there are numerous pathways that may be 
involved in IBV infection. For example, the NFκB pathway is known to be activated 
by AKT signalling and is involved in the antiviral response. Investigation into the 
activity of the pathway during IBV infection may elucidate the cause for the biphasic 
activation of AKT seen in Chapter 3. It is possible that the early phase of activation 
is an anti-viral response to infection and may involve the NFκB pathway.  
Whilst this project focused mainly on the role of the PI3K/AKT signalling pathway 
during IBV infection. The involvement of many cellular signalling pathways during 
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IBV infection could be established by performing a phosphoproteomic study. This 
would allow us to map the activated pathways in both uninfected and infected cells 
to identify which are being modulated by the virus 
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5.1 Introduction 
The protein kinase, AKT plays a critical role in the regulation of cell growth and 
survival. It is a member of the AGC kinase family that consists of approximately 60 
members that are phosphorylated at serine or threonine residues (Fayard et al., 
2005). There are three isoforms of mammalian AKT, AKT1, AKT2, and AKT3 which 
exhibit strong homology in their catalytic domains. However, the functions of each 
isoform differ. The human AKT genes have been well characterised and their 
location on the human genome identified (Table 5.1). AKT1 is present on 
chromosome 14, AKT2 on chromosome 19 and AKT3 on chromosome 1.  
 
The expression profile of the AKT genes in human tissues has been well 
investigated (Figure 5.1). AKT1 is the most widely expressed of the three genes and 
is found in most tissues at high levels (Stambolic and Woodgett, 2006). AKT2 is 
expressed at lower levels than AKT1 and at lower levels in the brain and liver 
compared to other tissues. The third isoform, AKT3, is expressed in high levels in 
the brain and muscle but in low levels in other tissues. The expression patterns of 
the genes can provide an insight into the function of the encoded proteins. There is 
strong homology in their catalytic domains with between 87% and 90% identical 
amino acids. However, despite this homology, the expression and function of each 
isoform is different. For example, AKT2 is known to be an important factor in insulin 
signalling (Cho et al., 2001a) and AKT1 is involved in anti-apoptotic signalling and 
promotes cell survival (Dummler et al., 2006, Chen et al., 2001). The function of 
AKT3 is less well characterised, however, mice lacking the protein develop smaller 
brains, suggesting that it is involved in neural development (Easton et al., 2005).  
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5.2 Avian isoforms of AKT 
There is little known about the avian AKT genes with only two of the three predicted 
isoforms mapped in the chicken genome. In this chapter the avian AKT isoforms are 
discussed, the tissue distribution determined and expression in the context of IBV 
infection investigated.  
5.2.1 Location of AKT genes 
A search of the Gallus gallus genome revealed that only chicken AKT1 (chAKT1) 
and chicken AKT3 (chAKT3) had been identified and mapped (Table 5.2). chAKT1 
is present on chromosome 5 and chAKT3 on chromosome 3 of the chicken genome. 
The third isoform remains unmapped on the chicken genome.   
5.2.2 The search for chAKT2 
Initially, a search of the chicken genome (Galgal4) resulted in the identification of a 
partial cds of the Gallus gallus protein serine/threonine kinase (AKT2) mRNA 
(gi|5853304|gb|AF181260.1). A BLAT nucleotide search of the chicken genome, 
using the partial chAKT2 sequence, indicated that the gene had not been mapped in 
the genome. Two partial cds were highlighted with high identity to the original 
sequence. One sequence was within chAKT1 on chromosome 5 with 85% identity. 
The second was located on a scaffold (AADN03011991.1:177-301) with 99.2% 
identity. One of the closely related species to have a fully sequenced genome is the 
Duck. A search of the BGI_duck_1.0 genome resulted in the identification of all 
three AKT genes. The duck AKT2 gene was found to be positioned on a scaffold 
that had not been mapped to a chromosome, therefore it could not be used to check 
for synteny between the species. A BLAT nucleotide search using the duck AKT2 
sequence (ENSAPLG00000016235) was performed on the chicken genome. Two 
scaffolds were identified with high identity to the duck AKT2 sequence. One of the 
scaffolds had been identified previously, AADN03011991.1:175-301.  
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The other, AADN03013585.1:434-570 was found to have 88.32% identity to the 
duck sequence. This suggests that the gene exists in the chicken genome, and has 
been sequenced over several scaffolds. Unfortunately, these scaffolds have not 
been mapped to chromosomes as yet. An attempt to align the scaffolds and look for 
any overlap in the sequence was unsuccessful.   
5.3 Method development 
The expression of both chAKT isoforms was measured in a panel of tissues from 
uninfected and IBV infected chickens by quantitative real-time PCR (qPCR).  
The qPCR assay is widely used in many research contexts. Diagnostic techniques 
often rely on efficient, specific and reliable qPCR assays that are normalised to the 
expression of stable reference genes. Other studies that investigate differential 
expression of genes across experimental conditions, such as viral infection, also 
require normalisation. In these cases, it is important that target gene expression is 
normalised to reference genes that are known to be stable across the experimental 
conditions. The MIQE (Minimum Information for Publication of Quantitative Real-
Time PCR Experiments) guidelines published in 2009 (Bustin et al., 2009) provide a 
comprehensive list of requirements for the publication of qPCR research. In addition 
to discussion of publication requirements and nomenclature, it also discusses the 
selection of stable reference genes. The guidelines describe how reference genes, 
that are known to be stably expressed across all experimental conditions, should be 
initially selected. The primer/probe sets for the reference genes should be designed 
to amplify efficiently and not amplify DNA. The stability of the reference genes 
should then be assessed by use of algorithms such as geNorm (Vandesompele J., 
2002), BestKeeper (Pfaffl et al., 2004) or NormFinder (Andersen et al., 2004).  
Initially, to identify a panel of stable genes, an assortment of candidate reference 
genes were selected, primer/probe sets designed and stability assessed in a variety 
of experimental conditions. The oligonucleotide sequences were designed, tested 
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and optimised in collaboration with Karen Staines and William Mwangi and 
published (Staines et al., 2016). The effect of inappropriate normalisation on the 
analysis of qPCR assays has been investigated using IBV infection as a model and 
published (Appendix 4) (Batra et al., 2016).  
The schematic in Figure 5.2 describes the process by which reference genes can be 
selected, designed and included in an experimental set up. Genes that are expected 
to be stable across all experimental conditions are selected. Primers are designed 
and tested to ensure that they amplify efficiently and do not amplify genomic DNA. 
The qPCR can then be run using SYBR Green, or hydrolysis probes can be 
designed. It is recommended that each gene is tested on all samples, however in 
some cases a cross-representative subset is sufficient. The individual Cq 
(quantification cycle) values from each candidate reference gene can then be 
analysed using the geNorm, NormFinder or BestKeeper algorithm. This allows 
identification of the most stable reference genes for the experimental samples 
tested. The stable genes may subsequently be run alongside the target genes and 
used for normalisation. Also included is a description of experimental sample 
processing which aims to ensure minimal contamination of DNA.  
5.3.1 Selection of reference gene panel 
Initially a panel of candidate reference genes were selected based on a review of 
literature relating to mammalian and avian qPCR studies. All of the genes selected 
are known to be highly conserved in mammalian species and have orthologs in 
avian species. A description of the genes and the function of the encoded proteins is 
presented in Table 5.3.  
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5.3.2 Design of primer/probe sets for panel of reference genes 
The design of efficient and specific primer/probe sets for reference genes is important to 
ensure accurate normalisation of data. Several requirements for primer/probe design 
have been identified (Rodriguez et al., 2015) (Table 5.4). The guanine (G) and cytosine 
(C) content of both primer and hydrolysis probes must be between 30 – 80% with more 
G than C bases in the probes. The Tm of the primers should be between 55 – 60 °C and 
should not differ by more than 2 °C between the two. If the Tm of the forward and reverse 
primers differ by more than 2 °C hairpins may form. The probes should have a Tm of 
between 60 -70 °C and should be between 8 – 10 °C higher than that of the primer. 
Additionally, the primer and probes should both be between 15 – 30 base pairs (bp) in 
length and the products between 50 – 150 bp. To ensure stability, the last 5 bp of the 
primers should not contain more than two G or C bases and there should be a maximum 
of 3 runs of identical nucleotides, none of which should be Gs. The primers and probes 
were designed to amplify over an intron, with either one of the primers or the probe 
sequence spanning an intron. This ensured no amplification of gDNA. 
Primer and probe sets were designed for this study ensuring that the above 
requirements were taken into consideration. However, it was not always possible to fulfil 
the requirements due to the high GC content of avian genes. Initial selection of primer 
pairs was undertaken using GenScript (https://www.genscript.com/ssl-bin/app/primer) 
which allowed identification of a number of candidate oligonucleotide sequences. 
GenScript was preferred for initial assessment, as it provided a selection of oligo 
sequences at various positions across the gene. Candidates that spanned introns were 
selected for further optimisation. Primer Express (Applied Biosystems, Foster City, 
California, USA) was then used to choose the most appropriate oligonucleotide pairs 
from the candidates identified by GenScript as it allowed more stringent design and the 
implementation of more detailed criteria.  
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The selected primer pairs were tested experimentally by end-point PCR and agarose gel 
electrophoresis with RNA and DNA templates by Karen Staines (Staines et al., 2016). 
Only the primer pairs that produced a single product band of the expected size from the 
RNA template were chosen.   
5.3.3 Experimental testing of primer sets 
The primer sets in Table 5.5 were selected as they had produced only one band on an 
agarose gel from end-point PCR, and fulfilled the requirements for proper design as far 
as possible. In order to further confirm that the primers would efficiently amplify the 
respective genes, a SYBR Green qPCR was performed for each set. In all assays, the 
primer sets amplified cDNA at least 10 cycles below the no-reverse transcriptase (no-
RT) and no template control (NTC) (Figure 5.3A). A dissociation stage was included and 
melt curves produced for each set of primers (Figure 5.3B). Only the amplification and 
melt curves for ACTB are shown as a representative sample. Each melt curve showed a 
single peak suggesting the amplification of only one product. 
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5.4 Differential expression of chAKT1 and chAKT3 in avian 
tissues 
Using the gene sequences available for chAKT1 and chAKT3, primer and probes 
were designed for expression analysis. The primer and probe sets were designed by 
PrimerDesign Ltd (Methods section 2.1.3). Using the panel of reference genes 
designed and tested in section 5.3.1 (Table 5.5), expression of chAKT1 and chAKT3 
was normalised to optimised stable reference genes.  
Tissues were collected from 2 week old Rhode Island Red birds, lysed and RNA 
collected by TRIzol® extraction and subsequently purified on a Qiagen RNeasy 
column (Methods section 2.5.2). The tissues collected are listed below.  
Blood 
Brain 
Cecal Tonsil 
Heart 
Liver 
Bone Marrow 
Bursa 
Gut 
Kidney 
Lung 
Thymus 
Muscle 
Trachea 
Skin 
Several of the tissues collected were specific to birds. For example, the bursa of 
fabricius is a highly specialised lymphoid organ that is the site of hematopoiesis 
(Ratcliffe, 2006).  
To investigate the effects of viral infection on AKT expression, tissues that are 
known to be involved in viral replication or the host response were also selected. 
The avian cecal tonsils are also lymphoid organs that elicit protective immune 
responses against pathogens in the intestinal tract (Heidari et al., 2014). The 
trachea was selected as it is the primary site of replication for many avian viral 
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respiratory diseases, including IBV. The M41 strain of IBV is also known to infect the 
kidneys and cause nephropathogenisis. 
The stability of six candidate reference genes across the tissue panel was assessed 
by geNorm. TBP, PLA2, RPLPO, RPL13, HMBS and ACTB were chosen as a 
reference panel based on previous assays run by Staines et al, 2016. The qPCR 
was run using SYBR Green and employing the sample maximisation run layout that 
negates the need for inter-run calibration. The sample maximisation run layout 
involves analysing amplification of one gene across all samples on one plate. It is 
therefore not necessary to run the reference genes on the same plate as the target 
gene. This is useful when the number of samples does not allow every gene to be 
analysed on a single plate. The Cq values for each run were imported into the 
qbase+ [Biogazelle] software for geNorm analysis (Figure 5.4). The y-axis indicates 
the geNorm M value for each reference gene. The M value is a measure of the 
stability of the reference genes where, the lower the M value the more stable the 
genes. PLA2, with the lowest M value, represents the most stable gene across the 
samples. The next gene, TBP is the gene that produces the least change in the 
stability of the reaction. In this way the genes are ranked from least to most stable 
as, ACTB, HMBS, RPL13, RPLP0, TBP and PLA2.  The geNorm algorithm also 
recommends a suitable number of reference genes to use. In this case the software 
recommended the use of the first three most stable genes, PLA2, TBP and RPLP0.  
The expression profiles of chAKT1 and chAKT3 were therefore assessed in the 
panel of chicken tissues and normalised to PLA2, TBP and RPLP0 expression 
(Figure 5.5).  
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TaqMan qPCR assays were run for chAKT1, chAKT3, PLA2, TBP and RPLP0. The 
Cq values for each gene were analysed using the qbase+ software and the relative 
expression of each gene across the tissue panel was determined (Figure 5.5). The 
expression of chAKT1 and chAKT3 was consistent in most tissues. However, 
expression of both genes was lower in the bursa than the other tissues. Expression 
of chAKT3 was significantly higher in the brain at 66.60 Rq (relative quantities) 
compared to 16.70 Rq of chAKT1. Chicken AKT3 expression was also significantly 
higher in the heart (1.61 Rq in chAKT3 expression compared to 0.54 Rq for 
chAKT1). In contrast, expression of chAKT3 in the blood is significantly lower than 
that of chAKT1. 
5.5 Differential expression of chAKT1 & chAKT3 in tissues during 
infection with IBV 
Infection of avian cells with IBV has been found to induce activation of the AKT 
protein (Chapter 3). It is not known however whether AKT activity is also modulated 
by gene expression. Therefore, the expression of chAKT1 and chAKT3 was 
measured in tissues collected from IBV infected birds.  
Eight-day old Rhode Island Red SPF birds were mock infected or infected with the 
M41 strain of IBV. At day 4, 6 and 7 post infection, tissues were collected and stored 
in RNAlater. The tissues were collected as part of an IBV challenge experiment and 
the type of tissue available for analysis was limited. RNA from samples of spleen, 
brain, kidney, lung and trachea was TRIzol extracted and subsequently purified on 
an RNeasy column. The RNA was then reverse transcribed into cDNA for the qPCR 
analysis.  
Initially, the level of IBV infection in each tissue, at all time-points, was assessed by 
qPCR. The number of copies of IBV genome was measured using primers that 
amplified the 5′ UTR of the genome (Figure 5.6).  
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Copy number was calculated from a standard curve and normalised to mock levels. 
Genome copy number was calculated as an indication of the presence of IBV virions 
within the tissue. Copies of viral genome were found in all tissues except the brain. 
Levels of IBV genome were significantly higher in the trachea at day 4 compared to 
other tissues, but decreased at day 6 and 7. Genome copy number increased in 
several birds at day 6 in the kidney however levels then dropped by day 7 post 
infection.  
The level of IBV infection was also investigated by qPCR using primers specific to 
the N-message region of the genome (Figure 5.7). This assay allowed the 
identification of replicating virus within the tissues, as viral mRNA is synthesised 
during active viral replication. Copy number was again inferred from a standard 
curve and normalised to mock levels. High levels of replicating virus was present in 
the trachea at day 4 which then decreased at day 6 and day 7. At day 6 several of 
the birds had more copies of viral mRNA in the kidney and lung than at day 4. By 
day 7 however, levels of replicating virus in the tissues decreased, suggesting that 
the virus was being cleared in those birds by day 7. Although replication virus levels 
were higher in the brain and spleen at day 4, and day 7, the copy number was 
extremely low and not thought to be biologically relevant.   
The stability of candidate reference genes in the mock infected and infected tissues 
was established by geNorm analysis (Figure 5.8). Reference genes were amplified 
in each tissues sample across each time point. The Cq values were imported into 
qbase+ and the stability of the reference genes ranked by geNorm M value. The 
reference genes were ranked from least to most stable as PLA2, ACTB, TBP, 
HMBS, RPL13 and RPLP0. The geNorm algorithm was again not able to 
recommend a suitable number of reference genes for this assay, therefore the three 
most stable reference genes, RPLP0, RPL13 and HMBS were used to normalise 
gene expression levels.  
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The expression of chAKT1 and chAKT3 were then measured in the tissues collected 
from mock infected and IBV infected birds at day 4, 6 and 7 post infection. The 
analysis of relative expression was performed using the qbase+ software. Levels of 
chAKT1 expression were normalised to expression of stable reference genes 
chosen by geNorm (Figure 5.9). There was no significant change in the expression 
of chAKT1 in any of the tissues at any day post infection between mock and infected 
tissues. However, there were large amounts of variation between birds, with several 
birds having high levels of expression in the spleen, brain and kidney compared to 
others.  
The expression of chAKT3 was normalised to levels of reference gene expression 
(Figure 5.10). Relative to chAKT1, expression of chAKT3 was lower in all samples 
except the brain. Expression of chAKT3 was significantly higher in the brain of IBV 
infected birds at day 7 compared to mock infected birds. Levels of chAKT3 
expression was also found to be statistically higher in the lung at day 7 in infected 
birds, however this was not expected to be biologically relevant.  
 
5.6 Discussion 
The design of primers and probes is one of the most important factors that affect the 
quality of qPCR experiments. In this chapter requirements for the design of primers 
and probes for qPCR studies are presented that have been established in 
mammalian systems (Table 5.4). Included in the requirements is the GC content of 
the primer and probes. It is suggested that both primer and probes should contain 
between 30-80% GC content. The high GC content of the avian genes often means 
that it is difficult to find areas of the target sequence that are not GC rich. GC rich 
sequences result in a reduction in amplification efficiency as they do not denature 
easily. 
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The GC content of the sequences will also have a direct effect on the melting 
temperature of the primers and probe (Rodriguez et al., 2015, Mitsuhashi, 1996b, 
Mitsuhashi, 1996a). 
The GC content was often more than 80% of the selected region of the target gene. 
As other constraints, such as the need for a long intron and missing sequence had 
to be accommodated, not all of the requirements for design were achieved. For 
example, some primers contained more than two GC bases at the 3' end. Priority 
was initially given to the design of primer and probes that would not amplify gDNA. 
Sequences identified using GenScript that spanned introns were selected and 
subsequently modified using Primer Express. It would be useful to re-evaluate and 
re-design a list of prerequisites for the design of avian primer/probes. These 
requirements could take into account the GC rich avian genes and establish a set of 
guidelines by which avian primer and probe sequences could be designed. These 
may be less stringent than the mammalian requirements and focus more on 
preventing the formation of secondary and tertiary structures, such as the tetra-plex 
structures formed from poly-C and G regions.  
Whilst the Gallus gallus genome has been fully sequenced, there remain many gaps 
where certain areas of the genome have not been mapped. From the available data, 
it seems likely that the chAKT2 gene resides within one of these gaps. Partial 
sequences of the gene appear to be spread across multiple scaffolds, including 
AADN03011991.1:175-301. However, the scaffolds do not align. Analysis of RNA 
sequencing data also suggests that the chAKT1 gene has been mis-annotated and 
is missing an exon (Paolo Ribeca, The Pirbright Institute, unpublished). It is 
expected that this will be rectified in the next annotation/assembly update.  
The stability of reference genes across the tissue panels was assessed using the 
geNorm algorithm (Vandesompele J., 2002). Other algorithms such as Normfinder 
are available, however our previous study has shown that both algorithms provide 
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similar results (Staines et al., 2016). The geNorm analysis of reference genes was 
performed using candidate sequences previously designed in Staines et al. 
(2016). In the current study, the algorithm was unable to select a suitable number 
of reference genes based on the calculated geNorm V values for the IBV infected 
sample set. This is potentially a result of small amounts of variation in the 
expression of the reference genes between the samples. Vandesompele J. (2002) 
suggest the use of the three most stable reference genes in situations where the 
optimal number could not be calculated.  
 
The expression of chAKT1 and chAKT3 mRNA across a panel of avian tissues 
was examined (Figure 5.5). In human tissues, AKT1 was the most abundant 
isotype and was expressed at higher levels in all tissues than AKT2 and AKT3. 
The same was not found for chAKT1, where levels of expression were not 
significantly different to chAKT3 in the majority of tissues. The similar expression 
levels of both chAKT1 and chAKT3 in the avian tissues suggests alternative roles 
for chAKT3 compared to those of human AKT3. However, it is also possible that 
human AKT3 is turned over faster than chAKT3. Like human AKT3, chAKT3 was 
expressed at significantly higher levels in the brain (66.6 Rq) than chAKT1 (16.7 
Rq). Expression of chAKT3 was also higher in the heart than chAKT1. This pattern 
of expression is not seen in human tissues and again suggests an alternative role 
for chAKT3 that has not yet been identified. The expression of both chAKT1 and 
chAKT3 was lower in the bursa than other tissues. The bursa of fabricious is the 
primary site of B cell development in the chicken. Interestingly, AKT is known to be 
involved in the complicated B-cell development signalling cascade (Limon and 
Fruman, 2012). Therefore, we would expect chAKTs to be expressed in higher 
levels in the bursal tissue. However, this is not the case and warrants further 
investigation.  
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Tissues from IBV infected birds were collected at days 4, 6 and 7 post infection. 
The level of IBV infection in each tissue was measured by qPCR. Two qPCR 
assays were performed that measured genome copy number, representing the 
presence of virus in the tissues, and viral mRNA copy number, to represent 
replicating virus in the tissues. The birds were inoculated via the ocular/nasal 
route, and therefore one of the primary sites of infection is the trachea. At day 4 
both viral genome and mRNA was found at higher levels in the trachea than any 
other tissue (Figure 5.6 & 5.7). Viral copy number then drops in the trachea at 
days 6 and 7 post infection as the infection is cleared. This is consistent with other 
studies that have shown the highest levels of infection between 2-5 dpi, and also 
noted an absence of clinical signs by day 7 post infection (Armesto et al., 2011, 
Hodgson et al., 2004). There are large amounts of variation in the viral infection of 
tissues between the different birds. However, it is interesting to note that whilst 
viral genome and mRNA copy number drops in the trachea it increases in other 
tissues at day 6 post infection in certain birds. For example, genome copy number 
is 4 log higher in the kidney at day 6 than at day 4 and infection is confirmed by 
viral mRNA copy number increasing by 2 log (Figure 5.6 and 5.7). The spleen and 
lung also have higher genome copy numbers at day 6 compared to day 4, 
however no N-message was detected. The brain, in contrast had very low copy 
number of both genome and viral mRNA at all days post infection.  
 
At day 7 post infection the amount of virus present in the tissues, as measured by 
genome copy number, does not seem to alter from day 6. There are high levels in 
the kidney and lung with lower levels in the spleen, trachea, and negligible levels 
in the brain. Viral mRNA copy number however, representing the amount of 
replicating virus present, decreases by 2 log in the kidney from day 6 to day 7. 
This data suggests that there is an initial established infection of the trachea at day 
4 post infection, by day 6 there is virus present in the kidney and lung however 
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replicating virus is cleared by day 7 in the kidney. No previous studies have 
investigated the tissue distribution of IBV during infection. The M41 strain of IBV is 
known to be nephropathogenic, however it is not known how the virus is 
transported to the kidneys (Cavanagh, 2007). The results presented here suggest 
that the virus is transported to other organs, such as the spleen, but is not able to 
establish an infection. This may be due to the specificity of the spike protein and 
the absence of the cellular receptor in splenocytes.   
 
The expression of chAKT1 in tissues collected from mock infected or IBV infected 
birds was measured by qPCR (Figure 5.8). Levels of chAKT1 expression did not 
change significantly in any of the tissues during infection at any day post infection. 
However, expression of chAKT1 was found to be higher in the brain than other 
tissues in the uninfected tissue panel (Figure 5.5). This was not reflected in the 
mock infected data in Figure 5.9 and expression of chAKT1 in the brain of infected 
birds was higher in several replicates.  
 
Levels of chAKT3 expression in infected birds were significantly higher in the brain 
and lung at 7 days post infection compared to mock. Although statistically 
significant, the increase in chAKT3 expression in the lung was minimal. The viral 
genome and mRNA copy number were very low in the lung at day 7, suggesting 
that the infection had been cleared. No viral infection was detected in the brain at 
any time point. This suggests that the increase in chAKT3 expression was an 
indirect response to an overall viral infection in the bird. Expression of chAKT3 
may have been triggered as a response to stress or immune reaction stimulated 
by IBV infection.  
 
Whilst every effort was taken to ensure that tissue samples were collected from 
the same area of the tissue, and as quickly as possible to minimise degradation, 
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there remains a large spread in the expression of chAKT1 and chAKT3 in the 
different birds. The levels of viral infection in the trachea of each bird also vary, 
likely due to phenotypic differences between the birds and efficacy of infection. 
The spread in the expression data of chAKT1 and chAKT3 suggests that there is 
no significant change in expression during IBV infection. However, this is not 
conclusive due to the natural high variation in the biological systems used.  
 
The data from this study suggests that IBV infection does not induce modulation of 
chAKT gene expression in the tissues examined. However, IBV infection does 
induce an increase in chAKT3, and potentially chAKT1, expression in the brain by 
day 7 post infection, independently of tissue infection.  
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5.7 Summary 
chAKT2 
 Has not been mapped in the chicken genome 
 Partial sequences have been identified over several scaffolds of the 
sequenced genomes 
chAKT1 
 Is expressed in all of the avian tissues tested  
 Is expressed in blood at higher levels than chAKT3 
 Expression is not significantly affected by infection of the bird or tissues with 
IBV 
chAKT3 
 Is expressed in all of the avian tissues tested 
 Is expressed in the brain and heart at higher levels than chAKT1 
 Expression is not significantly affected by tissue specific infection 
 Expression is significantly higher in the brain during IBV infection of the bird, 
but independently of tissue infection 
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5.8 Future Work 
An initial nucleotide search of the chicken genome suggested that chAKT2 exists, 
however is yet to be mapped to a chromosomal location. Data from The Human 
Protein Atlas is invaluable for studies of not only pathogen-host interactions, but 
also development and cancer. There is comparatively very little known about the 
proteome of Gallus gallus which often hinders complete and efficient research. 
This project is a good example of where this has happened. It would be beneficial 
to be able to compare the expression of chAKT2, in addition to chAKT1 and 
chAKT3 across a panel of avian tissues. 
 
The expression of chAKT1 and chAKT3 was normalised to reference genes 
selected by geNorm. As the optimal number of reference genes could not be 
calculated from the geNorm V values, the three most stable reference genes were 
used for normalisation of target mRNA levels. Whilst this is suitable in most cases, 
it would be beneficial to investigate the stability of further reference genes across 
these tissue panels.  
 
The differential pattern of chAKT1 and chAKT3 expression seen in chicken 
tissues, as compared to human tissues, suggests an alternative role for chAKT3 in 
chickens. Human AKT3 is documented to be expressed in high quantities in the 
brain but not in other tissues. AKT3 knockout mice were found to develop smaller 
brains compared to wild type (Easton et al., 2005). Therefore, it would be 
interesting to look at the protein level and investigate the functions of AKT1 and 
AKT3 in avian tissues. In particular, the role of AKT3 in the heart and brain.  
The lower expression of chAKT1 and chAKT3 in the Bursa, compared to other 
tissues, merits further investigation. The bursa of chickens is at its largest within a 
few weeks of hatch, after which it gets smaller and its function changes. The 
expression of chAKT1 and chAKT3 in the bursas of birds of different ages could 
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be investigated to understand more about the genes function. As the bursa is the 
primary site of B-cell development, it may be beneficial to investigate the role of 
AKT1 and AKT3 proteins in the development of B-cells. This could be done initially 
by investigating the pathways involved using specific antibodies to AKT1 and 
AKT3 in B-cells. Subsequently, the proteins could be overexpressed in the cells 
and the effect of overexpression investigated.  
Copies of IBV genome were detected in the spleen at day 6 and 7 post infection in 
several birds, however no viral mRNA was detected. This suggests that the virus 
is able to enter splenocytes but not replicate and establish an infection, as was 
seen in the kidney. The presence of virus in the spleen, kidney and lungs, but not 
the brain suggests that the virus may be transported to these sites in the blood. 
Little is known about how the virus establishes infections in organs outside the 
respiratory system. It would be interesting to investigate this further by measuring 
viral genome and mRNA levels in a further panel of tissues, including the blood 
and primary cells.  
 
The National Avian Research Facility (NARF) at The Roslin Institute, Edinburgh 
houses eight inbred lines of chicken, some of which are known to have varying 
susceptibility to avian viruses. It would also be interesting to examine the 
expression profile of the AKT isoforms in the different lines to establish whether 
AKT gene expression plays a role in viral pathogenesis.  
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6.1 Significance of this work 
The coronaviridae family of viruses infects many species of birds and mammals 
including humans. Over recent years’ coronaviruses have attracted much attention 
due to their ability to transmit between species. This was exemplified most recently 
by the emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) 
and also severe acute respiratory syndrome coronavirus (SARS-CoV). Both of these 
novel viruses were thought to originate in bats before crossing into the human 
population. Such zoonotic potential is concerning especially since global trade, 
deforestation, urbanization and high density farming practices increase the risk of 
severe zoonotic outbreaks. Of particular note are zoonotic avian diseases. In the UK 
alone there are around 875 million chickens produced in over 2,500 poultry farms 
each year (BPC, 2016). Over recent years the consumption of poultry has risen from 
77 to 86 million metric tons compared with consumption of beef and veal at only 55 
million metric tons (FAS, 2012). The vast quantities of poultry farmed for meat and 
egg production, as well as the quantity of domestic poultry kept for small scale 
farming, provides a perfect environment for the spread of a zoonotic avian virus. A 
recent example of this was the avian influenza H5N1 and H7N9, both of which have 
been found to cause disease in humans (Kandun  et al., 2006, Li  et al., 2014). 
There is presently no reason to expect the tropism of avian coronaviruses to extend 
to humans. However, further research into the pathogenicity and basic biology of the 
virus will be beneficial to economies and poultry industries worldwide and will inform 
study of related coronaviruses with potential significance to human health.  
The aim of this project was to identify the role of the PI3K/AKT signalling pathway 
during avian infectious bronchitis virus infection in the natural host. The study of the 
interactions between viruses and cellular pathways can often provide insights into 
viral replication that lead to the development of the next generation of vaccines or 
therapeutics. A key example of this occurred in the development of PI3K inhibitors 
for the treatment of IAV infections (Hsu et al., 2015). At the same time, 
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understanding the replication cycle and basic biology of viral infections often leads 
to the discovery of novel aspects of cell biology. In research fields such as avian 
virology, where knowledge about both avian viral replication and cell biology is often 
limited, these studies are vital for the progress of the field.  
 
6.2 Summary of results 
The main aim of this project was to investigate the role of the PI3K/AKT signalling 
pathway during IBV infection. The first objective was to identify the magnitude and 
duration of AKT activation in IBV infected cells. The results in this study suggest a 
biphasic activation in PI3K/AKT signalling during infection of avian cells.  The initial 
phase of activation was found to be dependent on viral attachment and entry into 
the cell, however, early activation was not seen to be dependent on viral replication. 
During the later phase of AKT activation, an active PI3K/AKT signalling pathway 
was identified as being necessary for viral replication. Interestingly, activation of 
PI3K/AKT signalling during IBV infection in mammalian cells was not found to be 
biphasic, with an increase in AKT activation seen only from 6 hpi.  
Subsequently, the effect of IBV-induced PI3K/AKT activation on protein synthesis, 
apoptosis and micropinocytosis was investigated. IBV infection of avian cells was 
found to induce phosphorylation of 4E-BP1 in a PI3K-dependent manner at 2 and 12 
hpi, suggesting activation of cap-dependent translation. The cleavage of caspase 
3/7 was seen to increase in a biphasic manner in IBV infected avian and mammalian 
cells. However, it was not found to be dependent on active PI3K in avian cells. Two 
methods were employed to investigate levels of macropinocytic activity during IBV 
infection. Unfortunately, due to a lack of functioning controls and variability in the 
growth of the cell lines, no conclusions could be drawn from these results.  
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In addition to investigating the effects of IBV infection on the phosphorylation state 
of AKT, levels of chAKT mRNA expression were also measured. Initially, the 
location of the chAKT2 gene was investigated as it has not been mapped to the 
chicken genome. The partial cds available for chAKT2 was mapped to two scaffolds, 
suggesting that it is present in the chicken genome but has not yet been mapped to 
a chromosome.  
In order to measure the expression of chAKT1 and chAKT3 in avian cells and 
tissues, reference genes were selected and primer and probe sets designed. The 
most stable reference genes, in each sample set, were then chosen by geNorm 
analysis. The stable reference genes were then used to normalise the expression of 
chAKT1 and chAKT3.  
The expression of chAKT1 and chAKT3 was investigated by qPCR in cell culture 
and in vivo following IBV infection. IBV infected DF1 cells demonstrated increased 
levels of chAKT1 expression during infection. However, this increase was minimal 
and not believed to be biologically relevant. The expression of both chAKT1 and 
chAKT3 was determined in tissue collected from chickens infected with IBV. No 
significant increase in gene expression was seen in IBV infected tissues. However, 
an increase in chAKT3 expression was noted in the brain of IBV infected cells, 
despite the absence of virus in the tissue.  
6.3 The role of PI3K/AKT signalling during infection of avian cells 
In this study the PI3K/AKT signalling pathway was found to be activated during IBV 
infection of both mammalian and avian cells. The characteristics of AKT activation 
differed between IBV infected avian and mammalian cells. Activation of mammalian 
AKT occurred from 6 hpi continuing to 24 hpi, however activation of avian AKT 
occurred in a biphasic manner. The difference in the patterns of AKT activation 
between the species suggest differences in the interaction between the virus and 
avian or mammalian cells. Other studies have also noted differences in the 
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interaction between IBV and avian or mammalian cells. For example, autophagy has 
been found to occur in Vero cells, but not avian CK or DF1 cells during IBV infection 
(Maier et al., 2013a). These differences in virus-host interactions may be a result of 
the inability of the avian virus to stimulate mammalian signalling pathways. 
Alternatively, the early phase of AKT activation in avian cells may be an anti-viral 
response elicited by the cell. Mammalian cells may be slower to, or not able to elicit 
such a response during IBV infection.  
The role of AKT activation during IBV infection of avian cells can be summarised as 
follows (Figure 7.1).  
(i) The binding of the virus to cell surface sugars, and potentially other 
receptors, induces activation of AKT as early as 30 mins post infection.  
(ii) The virus enters the cell and the viral genome is released into the 
cytoplasm. Viral mRNA and genome is replicated, possibly in spherules 
attached to zippered-ER (Maier et al., 2013b). This process is dependent 
on an active PI3K/AKT signalling pathway and is supressed by treatment 
with the PI3K inhibitor LY294002. In CK cells viral mRNA, and in 
particular N-message, is replicated from 2-3 hpi. Viral genome however 
is only seen from 4-5 hpi (Maier et al., 2013b).  
(iii) Viral RNA is translated by the host machinery to synthesise viral 
proteins. Synthesis of viral proteins was also dependent on an active 
PI3K/AKT signalling pathway. However, this may be a result of 
suppression of viral RNA replication. The overexpression of IBV E may 
be involved in the activation of AKT, suggesting that activation of AKT 
during this stage of IBV infection could be a result of the expression of E.  
(iv) Viral proteins assemble at the ERGIC along with viral genome to form 
new virions.  
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(v) The new virions are then trafficked to the plasma membrane where they 
are released by exocytosis. Release of infectious particles was 
supressed by inhibition of PI3K, potentially as a result of a reduction in 
viral RNA replication and protein synthesis.  
The activation of avian AKT during IBV infection occurs in a biphasic manner. A 
model for the proposed role of PI3K/AKT signalling during IBV infection is depicted 
in Figure 7.2. In summary, it is hypothesised that avian cell infection with IBV 
induces cellular signalling modulation that occurs in three distinct phases. These 
were characterised initially by activation of AKT signalling.  
(A) The 1st phase of infection results in activation of AKT at 2 hpi, which is then 
supressed by 8hpi. This period of pAKT suppression is represented as the 2nd 
phase. By 16 hpi AKT activation is again restored and occurs until 24 hpi which 
represents the 3rd phase of IBV infection and is PI3K dependent (Figure 7.2 - Line 
A).  
This study investigated the modulation of several pathways downstream of 
PI3K/AKT signalling and together with other published data, models for their role in 
IBV infection of avian cells is summarized (Figure 7.2 lines B-D). (B) The cleavage 
of caspase 3/7 was found to coincide with all phases of IBV infection, however 
activation of the caspase cascade was found to be PI3K-independent. As with AKT, 
caspase cleavage is supressed during the second phase of infection. The UPR is 
known to be induced early during infection, before 8hpi (Fung et al., 2014). The 
activation of the caspase cascade may therefore be supressed by the UPR by 8 hpi 
(as seen in the 2nd phase of infection). This process has previously been suggested 
to occur via AKT and JNK. However, in this study the level of caspase cleavage was 
not found to be dependent on PI3K (Fung et al., 2014).  During the 3rd phase of 
infection there is again an increase in caspase cleavage which was not dependent 
on PI3K. This increase in pro-apoptotic signalling is possibly induced by ER-stress.  
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Whilst this would normally be controlled by the UPR, infection with IBV imposes a 
heavy burden on the ER which may overload the UPR and induce apoptosis.  
(C) Inhibition of GSK3-β by phosphorylation at S9 was found to occur at 2 hpi 
however data suggests a similar biphasic pattern of phosphorylation as seen with 
AKT. The pro-apoptotic nature of GSK3-β suggests that it’s inhibition by PI3K/AKT 
may be a survival mechanism to prevent apoptosis and cell death. Viral sgRNA is 
made from as early as 2 hpi therefore, a build-up of viral protein will have occurred 
by 8 hpi and stress put on cellular machinery.  
(D) PI3K/AKT signalling is also involved in the phosphorylation of 4E-BP1 at T37/46 
which primes the protein for phosphorylation at T70 and S65, resulting in its 
dissociation eIF4E. The phosphorylation 4E-BP1 occurred during the initial phase of 
infection and continued to 12 hpi. This phosphorylation of the 4E-BP1 is 
hypothesised to result in an increase in translation. Previous studies of IBV infection 
have demonstrated host translational shutoff during infection of CK, Vero and DF1 
cells (Kint et al., 2016). The accessory protein 5b was found to be involved in 
suppression of host translation, and infection with a 5b deletion mutant induced 
higher concentration of type 1 interferon. This suggests a role for 5b in the 
suppression of host innate immune responses to infection. Our data on 4E-BP1 
does not correlate with the findings of host shut-off as it suggests an increase in 
translation. However, viral translation may be specifically modulated through the 
phosphorylation of 4E-BP1. The mechanism for host shut-off during IBV infection is 
not fully understood. However, the activation of the UPR response involves the 
activation of PERK which directly phosphorylated eIF2α to decrease protein 
synthesis (Rajesh et al., 2015). It is therefore possible that IBV induces host shut-off 
through activation of the UPR response. The phosphorylation of 4E-BP1 seen in this 
study may be a by-product of the activation of AKT to stimulate another pathway. 
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Alternatively, the phosphorylation of 4E-BP1 during the 1st phase of infection may be 
a response elicited by the cell to promote an innate immune response.  
In addition to the activation of PI3K/AKT signalling, IBV infection has been found to 
induce autophagy during the 3rd phase of replication in mammalian cells (Cottam et 
al., 2011, Maier et al., 2013a). Whilst the role of PI3K/AKT signalling during IBV 
induced autophagy was not investigated in this project, it is likely to be involved, at 
least in mammalian cells. Activation of autophagy can be a pro- or anti-viral 
response. For example, replication of the Herpes Simplex virus 1 (HSV-1) and 
Sindbis viruses is inhibited by autophagy and inhibition of the pathway leads to 
increased replication and virulence (English et al., 2009, Orvedahl et al., 2010). The 
membranes required for autophagosome formation often originate from the 
endoplasmic reticulum. This initial step is controlled downstream of the PI3K/AKT 
signalling cascade, by mTOR. The mTOR signalling cascade inhibits autophagy 
when nutrients are available and conditions are favourable to promote growth. The 
activation of the PI3K/AKT/mTOR pathway would therefore be expected to prevent 
autophagy, however during the 3rd phase of infection the opposite occurs. MHV has 
been shown previously to induce autophagy in infected cells and along with other 
CoVs (Prentice et al., 2004). However, again the exact mechanism behind this 
activation is unknown.  
In conclusion, the initial phase of PI3K/AKT signalling is hypothesised to be a 
preliminary anti-viral response elicited by the cell as a result of virus infection. This 
anti-viral response is subsequently supressed by viral factors that work on the host 
pathways to prevent cell shut-down and death. These may include the accessory 
protein 5b which is involved in translational control and the suppression of the 
interferon response (Kint et al., 2016). By the 3rd phase of infection, viral factors 
activate PI3K/AKT signalling and other pathways to modulate processes that are 
beneficial to replication, for example apoptotic signalling.  
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This study highlights the importance of the PI3K/AKT signalling pathway in viral 
infection and also points to differences in viral modulation of cellular pathways in 
avian and mammalian cells. 
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Appendix 4 – Reference genes for qPCR in IBV studies, Batra et al (2016) 
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